⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6361873 | 0.77 | — | — | |
| SCHEMBL31659396 | 0.77 | KCNA4 (0.38) | — | |
| SCHEMBL13024562 | 0.73 | EPHX1 (0.58) | — | |
| SCHEMBL272618 | 0.71 | — | — | |
| SCHEMBL1940133 | 0.69 | — | — | |
| SCHEMBL6555583 | 0.69 | — | — | |
| SCHEMBL18149622 | 0.69 | — | — | |
| SCHEMBL1476358 | 0.69 | — | — | |
| SCHEMBL282689 | 0.69 | — | — | |
| SCHEMBL523978 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 738 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117486929-A | Substituted alkyl germanium compound and modularized synthesis method thereof | 西安交通大学 | 2024-02-02 | — | — | CN | claimed |
| US-11136433-B2 | Self-healing copolymerized polycarbonate and preparation method therefor | PUYANG SHENGTONGJUYUAN ADVANCED MATERIALS CO., LTD. (CN) | 2021-10-05 | — | — | US | claimed |
| US-20200308345-A1 | SELF-HEALING COPOLYMERIZED POLYCARBONATE AND PREPARATION METHOD THEREFOR | PUYANG SHENGTONGJUYUAN ADVANCED MATERIALS CO., LTD. (CN) | 2020-10-01 | — | — | US | claimed |
| WO-2020192381-A1 | COPOLYMER POLYCARBONATE HAVING SELF-REPAIRING FUNCTION AND PREPARATION METHOD THEREFOR | 北京濮源新材料技术研究院(普通合伙) | 2020-10-01 | — | — | WO | claimed |
| EP-1389224-A2 | POLYMERIC SURFACTANTS DERIVED FROM CYCLIC MONOMERS HAVING PENDANT FLUORINATED CARBON GROUPS | Omnova Soltions Inc (US) | 2004-02-18 | — | — | EP | claimed |
| US-6660828-B2 | Powder coating; fluorinated polyoxetanes; addition-condensation copolymer | OMNOVA SOLUTIONS INC. | 2003-12-09 | — | — | US | claimed |
| US-20030208015-A1 | Monohydric polyfluorooxetane oligomers, polymers, and copolymers and coatings containing the same | OMNOVA SOLUTIONS INC. | 2003-11-06 | — | — | US | claimed |
| US-20030149186-A1 | Monohydric polyfluorooxetane oligomers, polymers, and copolymers and coating containing the same | OMNOVA SOLUTIONS INC | 2003-08-07 | — | — | US | claimed |
| US-20030092862-A1 | Fluorinated short carbon atom side chain and polar group containing polymer, and flow, or leveling, or wetting agents thereof | OMNOVA SOLUTIONS INC. | 2003-05-15 | — | — | US | claimed |
| US-20030060571-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2003-03-27 | — | — | US | claimed |
| WO-2002092660-A2 | POLYMERIC SURFACTANTS DERIVED FROM CYCLIC MONOMERS HAVING PENDANT FLUORINATED CARBON GROUPS | OMNOVA SOLTIONS INC (US) | 2002-11-21 | — | — | WO | claimed |
| US-20020156200-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2002-10-24 | — | — | US | claimed |
| US-20020143112-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2002-10-03 | — | — | US | claimed |
| EP-1244727-A1 | MONOHYDRIC POLYFLUOROOXETANE OLIGOMERS, POLYMERS, AND COPOLYMERS AND COATINGS CONTAINING THE SAME | OMNOVA SOLUTIONS INC. (US) | 2002-10-02 | — | — | EP | claimed |
| US-20020137853-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2002-09-26 | — | — | US | claimed |
| WO-2001048051-A1 | MONOHYDRIC POLYFLUOROOXETANE OLIGOMERS, POLYMERS, AND COPOLYMERS AND COATINGS CONTAINING THE SAME | OMNOVA SOLUTIONS, INC. (US) | 2001-07-05 | — | — | WO | claimed |
| EP-0811004-A4 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET GENERAL CO (US) | 1998-09-30 | — | — | EP | claimed |
| EP-0811004-A1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 1997-12-10 | — | — | EP | claimed |
| WO-1996021657-A1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 1996-07-18 | — | — | WO | claimed |
| EP-4747233-A2 | COMPOUNDS, COMPOSITIONS CONTAINING COMPOUNDS, AND METHODS OF MANUFACTURING RESIST MEMBRANES | Merck Patent GmbH (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260116881-A1 | KIF MODULATOR COMPOUNDS AND METHODS OF USE | IAMBIC THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4694874-A2 | GPX4 INHIBITORS AND SENOLYTIC COMPOUNDS AND USES THEREOF | Rubedo Life Sciences, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260007689-A1 | GPX4 Inhibitors and Senolytic Compounds and Uses Thereof | RUBEDO LIFE SCIENCES INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-20250368627-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | Peloton Therapeutics, Inc., a fully owned subsidiary of Merck Sharp & Dohme LLC (US) | 2025-12-04 | — | — | US | disclosed |
| US-12485132-B2 | GPX4 inhibitors and senolytic compounds and uses thereof | Rubedo Life Sciences, Inc. (US) | 2025-12-02 | — | — | US | disclosed |
| US-12466821-B2 | Antiviral pyridopyrazinedione compounds | NOVARTIS AG (CH) | 2025-11-11 | — | — | US | disclosed |
| US-20250319109-A1 | GPX4 Inhibitors and Senolytic Compounds and Uses Thereof | RUBEDO LIFE SCIENCES INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-12435066-B2 | Substituted tricyclic compounds | LUPIN LIMITED (IN) | 2025-10-07 | — | — | US | disclosed |
| US-20250282762-A1 | PYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF | NOVARTIS AG (CH) | 2025-09-11 | — | — | US | disclosed |
| WO-2025129167-A1 | INHIBITORS OF THE SURFACE EXPRESSION OF THE VOLTAGE-GATED SODIUM ION CHANNEL 1.7 (NAV1.7) AND THEIR THERAPEUTIC USES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-114948963-B | Benzolactam compounds as protein kinase inhibitors | 大冢制药株式会社 | 2025-05-27 | — | — | CN | disclosed |
| US-20250154169-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. | 2025-05-15 | — | — | US | disclosed |
| EP-4539840-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | Neuron23, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-119730846-A | Kinase modulators and methods of use thereof | 神经元23公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119707930-A | Aromatic ring compound and its prepn and use | 甘李药业股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-12252482-B2 | Pyrazolopyridine derivatives and uses thereof | NOVARTIS AG (CH) | 2025-03-18 | — | — | US | disclosed |
| CN-114163437-B | Substituted pyrazolo [1,5-a ] pyridine compounds as RET kinase inhibitors | 阿雷生物药品公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119390705-A | 5-Oxa-2-azaspiro [3.4] octane derivatives as M4 agonists | 诺华股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| WO-2025017121-A2 | COMPOUNDS, COMPOSITIONS CONTAINING COMPOUNDS, AND METHODS OF MANUFACTURING RESIST MEMBRANES | MERCK PATENT GMBH (DE) | 2025-01-23 | — | — | WO | disclosed |
| US-20250002479-A1 | PYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2025-01-02 | — | — | US | disclosed |
| US-12172984-B2 | Pyrazolopyridine derivatives and uses thereof | NOVARTIS AG (CH) | 2024-12-24 | — | — | US | disclosed |
| US-20240408124-A1 | GPX4 Inhibitors and Senolytic Compounds and Uses Thereof | Rubedo Life Sciences, Inc. | 2024-12-12 | — | — | US | disclosed |
| WO-2024249613-A2 | GPX4 INHIBITORS AND SENOLYTIC COMPOUNDS AND USES THEREOF | Rubedo Life Sciences, Inc. (US) | 2024-12-05 | — | — | WO | disclosed |
| EP-3953331-B1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | PELOTON THERAPEUTICS INC (US) | 2024-11-20 | — | — | EP | disclosed |
| US-12144816-B2 | Substituted indole Mcl-1 inhibitors | VANDERBILT UNIVERSITY (US) | 2024-11-19 | — | — | US | disclosed |
| US-20240368136-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-11-07 | — | — | US | disclosed |
| CN-114555606-B | 5-Oxa-2-azaspiro [3.4] octane derivatives as M4 agonists | 诺华股份有限公司 | 2024-10-01 | — | — | CN | disclosed |
| WO-2023244788-A9 | KINASE MODULATORS AND METHODS OF USE THEREOF | NEURON23, INC. (US) | 2024-09-12 | — | — | WO | disclosed |
| EP-3365334-B1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMA CO LTD (JP) | 2024-07-17 | — | — | EP | disclosed |
| EP-4395892-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | Remix Therapeutics Inc. (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-118302426-A | Compounds and methods for modulating splicing | 雷密克斯医疗公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-115515956-B | Benzimidazole derivative, and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-114746411-B | Substituted tricyclic compounds | 印度鲁宾有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-12012392-B2 | Sulfonamide carboxamide compounds | INFLAZOME LIMITED (IE) | 2024-06-18 | — | — | US | disclosed |
| US-11998545-B2 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2024-06-04 | — | — | US | disclosed |
| CN-116284040-B | Nitrogen-containing heterocyclic compound and medical application thereof | 华润医药研究院（深圳）有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20240158374-A1 | Pyrazolopyridine Derivatives and Uses thereof | NOVARTIS AG (CH) | 2024-05-16 | — | — | US | disclosed |
| CN-118019817-A | Sheet-like curable adhesive and optical member | 琳得科株式会社 | 2024-05-10 | — | — | CN | disclosed |
| US-20240140959-A1 | 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS | NOVARTIS AG (CH) | 2024-05-02 | — | — | US | disclosed |
| CN-117887341-A | Non-silicon release agent composition, coating method and preparation method of long-chain alkyl polyether thereof | 安庆龙驰氟硅新材料有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11939321-B2 | Benzolactam compounds as protein kinase inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-03-26 | — | — | US | disclosed |
| CN-117624139-A | Diaryl compound, preparation method and application thereof | 武汉人福创新药物研发中心有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-20240066029-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2024-02-29 | — | — | US | disclosed |
| WO-2024041628-A1 | DIARYL COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 武汉人福创新药物研发中心有限公司 | 2024-02-29 | — | — | WO | disclosed |
| US-20240051951-A1 | BICYCLIC COMPOUND AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2024-02-15 | — | — | US | disclosed |
| CN-117486929-A | Substituted alkyl germanium compound and modularized synthesis method thereof | 西安交通大学 | 2024-02-02 | — | — | CN | disclosed |
| EP-4065575-B1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LTD (IN) | 2024-01-31 | — | — | EP | disclosed |
| US-20240025906-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | SUNDANCE BIOSCIENCES, INC. | 2024-01-25 | — | — | US | disclosed |
| WO-2024018403-A1 | SUBSTITUTED IMIDAZOAMIDE COMPOUNDS, AND METHODS USING SAME | ARBUTUS BIOPHARMA CORPORATION (CA) | 2024-01-25 | — | — | WO | disclosed |
| EP-4308562-A1 | PYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF | Novartis AG (CH) | 2024-01-24 | — | — | EP | disclosed |
| US-20240018137-A1 | COMPOUND, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, POLYMER, HOLOGRAPHIC RECORDING MEDIUM, OPTICAL MATERIAL, AND OPTICAL COMPONENT | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-01-18 | — | — | US | disclosed |
| WO-2023244788-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | NEURON23, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| EP-4292662-A2 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | Vanderbilt University (US) | 2023-12-20 | — | — | EP | disclosed |
| US-11820778-B2 | 2-azaspiro[3.4]octane derivatives as M4 agonists | NOVARTIS AG (CH) | 2023-11-21 | — | — | US | disclosed |
| US-20230339886-A1 | REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-10-26 | — | — | US | disclosed |
| US-20230330099-A1 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | VANDERBILT UNIVERSITY | 2023-10-19 | — | — | US | disclosed |
| US-20230331768-A1 | OXYSTEROLS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. | 2023-10-19 | — | — | US | disclosed |
| US-20230331768-A1 | OXYSTEROLS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. | 2023-10-19 | — | — | US | disclosed |
| US-11787785-B2 | Pyrazolopyridine derivatives and uses thereof | NOVARTIS AG (CH) | 2023-10-17 | — | — | US | disclosed |
| US-11787785-B2 | Pyrazolopyridine derivatives and uses thereof | NOVARTIS AG (CH) | 2023-10-17 | — | — | US | disclosed |
| US-11787785-B2 | Pyrazolopyridine derivatives and uses thereof | NOVARTIS AG (CH) | 2023-10-17 | — | — | US | disclosed |
| CN-116789670-A | Selective CSF1R inhibitor and application thereof | 中国科学院合肥物质科学研究院 | 2023-09-22 | — | — | CN | disclosed |
| CN-116802182-A | Pyrazolopyridine derivatives and uses thereof | 诺华股份有限公司 | 2023-09-22 | — | — | CN | disclosed |
| WO-2023173480-A1 | SELECTIVE CSF1R INHIBITOR AND USE THEREOF | 中国科学院合肥物质科学研究院 | 2023-09-21 | — | — | WO | disclosed |
| US-20230286965-A1 | BICYCLIC COMPOUND AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| EP-3423435-B1 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | UNIV VANDERBILT (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023154344-A1 | 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-08-17 | — | — | WO | disclosed |
| US-11725001-B2 | Bicyclic compound and use thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2023-08-15 | — | — | US | disclosed |
| EP-3529256-B1 | OXYSTEROLS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS INC (US) | 2023-08-09 | — | — | EP | disclosed |
| US-11697636-B2 | Substituted benzamides | HOFFMANN-LA ROCHE INC. (US) | 2023-07-11 | — | — | US | disclosed |
| US-20230203043-A1 | NOVEL IMIDAZOPYRAZINE DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 2023-06-29 | — | — | US | disclosed |
| CN-116284040-A | Nitrogen-containing heterocyclic compound and medical application thereof | 华润医药研究院（深圳）有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20230135152-A1 | PIKFYVE KINASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-04 | — | — | US | disclosed |
| US-20230108325-A1 | Pyrazolopyridine Derivatives and Uses thereof | NOVARTIS AG (CH) | 2023-04-06 | — | — | US | disclosed |
| WO-2023054449-A1 | SHEET-LIKE CURABLE ADHESIVE AND OPTICAL MEMBER | リンテック株式会社 | 2023-04-06 | — | — | WO | disclosed |
| CN-110831942-B | Fused indazolopyridinone compounds as antiviral agents | 诺华股份有限公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115884970-A | Aryl formamide compound and preparation method and medical application thereof | 中国医药研究开发中心有限公司 | 2023-03-31 | — | — | CN | disclosed |
| US-20230090520-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2023-03-23 | — | — | US | disclosed |
| WO-2023034812-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. (US) | 2023-03-09 | — | — | WO | disclosed |
| US-11596639-B2 | Substituted indole Mcl-1 inhibitors | VANDERBILT UNIVERSITY (US) | 2023-03-07 | — | — | US | disclosed |
| EP-3727378-B1 | PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | MERCK SHARP & DOHME LLC (US) | 2023-02-22 | — | — | EP | disclosed |
| US-20230052629-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2023-02-16 | — | — | US | disclosed |
| WO-2023015236-A2 | COMPOSITION AND METHOD FOR TREATMENT OF GRAM NEGATIVE BACTERIAL INFECTION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2023-02-09 | — | — | WO | disclosed |
| CN-115677729-A | AAK1 inhibitors | 武汉人福创新药物研发中心有限公司 | 2023-02-03 | — | — | CN | disclosed |
| US-20230013778-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LIMITED (IN) | 2023-01-19 | — | — | US | disclosed |
| US-20230019032-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2023-01-19 | — | — | US | disclosed |
| US-20220411435-A1 | 2-AZASPIRO[3,4]OCTANE DERIVATIVES AS M4 AGONISTS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2022-12-29 | — | — | US | disclosed |
| CN-115515956-A | Benzimidazole derivative and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2022-12-23 | — | — | CN | disclosed |
| US-20220402902-A1 | BICYCLIC COMPOUND AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. | 2022-12-22 | — | — | US | disclosed |
| WO-2022266426-A1 | 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF | BLACK DIAMOND THERAPEUTICS, INC. (US) | 2022-12-22 | — | — | WO | disclosed |
| EP-4103281-A1 | PIKFYVE KINASE INHIBITORS | Acurastem Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| EP-4105223-A1 | OXYSTEROLS AND METHODS OF USE THEREOF | Sage Therapeutics, Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| US-11485742-B2 | 2-azaspiro[3.4]octane derivatives as M4 agonists | NOVARTIS AG (CH) | 2022-11-01 | — | — | US | disclosed |
| US-20220324860-A1 | SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2022-10-13 | — | — | US | disclosed |
| EP-4065575-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | Lupin Limited (IN) | 2022-10-05 | — | — | EP | disclosed |
| CN-110845702-B | Energy-curable hyperbranched epoxy resin, energy-curable composition containing same and application | 常州强力电子新材料股份有限公司 | 2022-09-30 | — | — | CN | disclosed |
| CN-110713580-B | Epoxy modified phenolic resin, preparation method thereof, composition containing epoxy modified phenolic resin and application thereof | 常州强力电子新材料股份有限公司 | 2022-09-30 | — | — | CN | disclosed |
| WO-2022195454-A1 | PYRAZOLOPYRIDINE DERIVATIVES AND USES THEREOF | NOVARTIS AG (CH) | 2022-09-22 | — | — | WO | disclosed |
| CN-114948963-A | Protein kinase inhibitor benzolactam compounds | 大冢制药株式会社 | 2022-08-30 | — | — | CN | disclosed |
| CN-114929691-A | Bicyclic compounds and uses thereof | 爱思开生物制药株式会社 | 2022-08-19 | — | — | CN | disclosed |
| EP-4041737-A1 | 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS | Novartis AG (CH) | 2022-08-17 | — | — | EP | disclosed |
| EP-4039686-A1 | BICYCLIC COMPOUND AND USE THEREOF | SK Biopharmaceuticals Co., Ltd. (KR) | 2022-08-10 | — | — | EP | disclosed |
| CN-110382496-B | Substituted pyrido [3,4-b ] indoles for the treatment of cartilage disorders | 赛诺菲 | 2022-08-09 | — | — | CN | disclosed |
| CN-114746411-A | Substituted tricyclic compounds | 印度鲁宾有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-109153643-B | Substituted indole MCL-1 inhibitors | 范德比尔特大学 | 2022-06-21 | — | — | CN | disclosed |
| CN-114555606-A | 5-oxa-2-azaspiro [3.4] octane derivatives as M4 agonists | 诺华股份有限公司 | 2022-05-27 | — | — | CN | disclosed |
| US-20220162193-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | PELOTON THERAPEUTICS, INC. (US) | 2022-05-26 | — | — | US | disclosed |
| EP-3998269-A1 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | Novartis AG (CH) | 2022-05-18 | — | — | EP | disclosed |
| CN-109790149-B | Phenoxytriazoles | 豪夫迈·罗氏有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-108617166-B | Protein kinase inhibitor benzolactam compounds | 大冢制药株式会社 | 2022-05-17 | — | — | CN | disclosed |
| US-11319314-B2 | Phenoxytriazoles | HOFFMANN-LA ROCHE INC. (US) | 2022-05-03 | — | — | US | disclosed |
| EP-3983073-A1 | SUBSTITUTED PYRAZOLO[4,3-B]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022068772-A1 | BENZIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF | 深圳信立泰药业股份有限公司 | 2022-04-07 | — | — | WO | disclosed |
| WO-2022068772-A1 | BENZIMIDAZOLE DERIVATIVE, AND PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF | 深圳信立泰药业股份有限公司 | 2022-04-07 | — | — | WO | disclosed |
| EP-3187490-B1 | SUBSTITUTED BENZAMIDE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2022-04-06 | — | — | EP | disclosed |
| WO-2022063205-A1 | ARYL FORMAMIDE COMPOUND, PREPARATION METHOD FOR SAME, AND MEDICINAL USES THEREOF | 中国医药研究开发中心有限公司 | 2022-03-31 | — | — | WO | disclosed |
| CN-114163437-A | Substituted pyrazolo [1,5-A ] pyridine compounds as RET kinase inhibitors | 阿雷生物药品公司 | 2022-03-11 | — | — | CN | disclosed |
| EP-3953331-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | Peloton Therapeutics, Inc. (US) | 2022-02-16 | — | — | EP | disclosed |
| CN-114014890-A | Compound with RIP2 kinase inhibitory activity, pharmaceutical composition containing same, and application thereof | 爱科诺生物医药(香港)有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-113993583-A | Substituted pyrazolo [4,3-b ] pyridines and their use as modulators of the GLUN2B receptor | 詹森药业有限公司 | 2022-01-28 | — | — | CN | disclosed |
| US-11179389-B2 | Purine inhibitors of human phosphatidylinositol 3-kinase delta | MERCK SHARP & DOHME CORP. (US) | 2021-11-23 | — | — | US | disclosed |
| CN-110382494-B | Substituted pyrazolo [1,5-A ] pyridine compounds as RET kinase inhibitors | 阿雷生物药品公司 | 2021-11-16 | — | — | CN | disclosed |
| US-11161846-B2 | Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators | JANSSEN PHARMACEUTICA NV (BE) | 2021-11-02 | — | — | US | disclosed |
| US-20210309653-A1 | PHENOXYTRIAZOLES | HOFFMANN-LA ROCHE INC. (US) | 2021-10-07 | — | — | US | disclosed |
| US-11136433-B2 | Self-healing copolymerized polycarbonate and preparation method therefor | PUYANG SHENGTONGJUYUAN ADVANCED MATERIALS CO., LTD. (CN) | 2021-10-05 | — | — | US | disclosed |
| US-11129819-B2 | Fumarate analogs and uses thereof | RIGEL PHARMACEUTICALS, INC. (US) | 2021-09-28 | — | — | US | disclosed |
| US-20210283138-A1 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | VANDERBILT UNIVERSITY | 2021-09-16 | — | — | US | disclosed |
| EP-3615533-B1 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | NOVARTIS AG (CH) | 2021-09-08 | — | — | EP | disclosed |
| EP-3720857-B1 | 2-OXO-5H-CHROMENO[4,3-B]PYRIDINES FOR USE IN THE TREATMENT OF HEPATITIS B | GALAPAGOS NV (BE) | 2021-09-08 | — | — | EP | disclosed |
| US-11111237-B2 | Bicyclic compound and use thereof | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2021-09-07 | — | — | US | disclosed |
| WO-2021163727-A1 | PIKFYVE KINASE INHIBITORS | AcuraStem Incorporated (US) | 2021-08-19 | — | — | WO | disclosed |
| WO-2021163727-A1 | PIKFYVE KINASE INHIBITORS | AcuraStem Incorporated (US) | 2021-08-19 | — | — | WO | disclosed |
| US-11072610-B2 | Antiviral pyridopyrazinedione compounds | NOVARTIS AG (CH) | 2021-07-27 | — | — | US | disclosed |
| EP-3849979-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | Novartis AG (CH) | 2021-07-21 | — | — | EP | disclosed |
| US-20210186959-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA, INC. | 2021-06-24 | — | — | US | disclosed |
| CN-112996789-A | Antiviral pyridopyrazinedione compounds | 诺华股份有限公司 | 2021-06-18 | — | — | CN | disclosed |
| EP-3538516-B1 | PHENOXYTRIAZOLES | HOFFMANN LA ROCHE (CH) | 2021-06-16 | — | — | EP | disclosed |
| WO-2021105960-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | LUPIN LIMITED (IN) | 2021-06-03 | — | — | WO | disclosed |
| CN-110713797-B | Epoxy grafted rosin, preparation method thereof, composition containing epoxy grafted rosin and application of composition | 常州强力电子新材料股份有限公司 | 2021-06-01 | — | — | CN | disclosed |
| CN-112851837-A | Safe and efficient preparation method of high-azide-content polymer | 商丘师范学院 | 2021-05-28 | — | — | CN | disclosed |
| EP-3822260-A1 | EPOXY MODIFIED ACRYLIC RESIN AND PREPARATION METHOD THEREFOR, AND ENERGY-CURABLE COMPOSITION CONTAINING EPOXY MODIFIED ACRYLIC RESIN AND APPLICATION | Changzhou Tronly New Electronic Materials Co., Ltd. (CN) | 2021-05-19 | — | — | EP | disclosed |
| US-11001575-B1 | Benzolactam compounds as protein kinase inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-05-11 | — | — | US | disclosed |
| US-11001569-B2 | 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2021-05-11 | — | — | US | disclosed |
| US-20210130365-A1 | 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2021-05-06 | — | — | US | disclosed |
| WO-2021070091-A1 | 5-OXA-2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS | NOVARTIS AG (CH) | 2021-04-15 | — | — | WO | disclosed |
| US-10975078-B2 | Fused indazole pyridone compounds as antivirals | NOVARTIS AG (CH) | 2021-04-13 | — | — | US | disclosed |
| US-20210101892-A1 | BICYCLIC COMPOUND AND USE THEREOF | SK BIOPHARMACEUTICALS CO., LTD. | 2021-04-08 | — | — | US | disclosed |
| US-10966980-B2 | Pyrrolo[2,3-d]pyrimidine derivatives | PFIZER INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-10953005-B1 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2021-03-23 | — | — | US | disclosed |
| CN-109311846-B | Novel 6-membered heteroaromatic substituted cyanoindole derivatives as NIK inhibitors | 杨森制药有限公司 | 2021-03-19 | — | — | CN | disclosed |
| US-20210061760-A1 | SUBSTITUTED BENZAMIDES | HOFFMANN LA ROCHE (US) | 2021-03-04 | — | — | US | disclosed |
| CN-106573901-B | Fumarate analogues and their use in the treatment of autoimmune or inflammatory diseases | 参宿七制药股份有限公司 | 2021-03-02 | — | — | CN | disclosed |
| EP-3042907-B1 | DGAT1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | QUINGDAO HUANGHAI PHARMACEUTICAL CO LTD (CN) | 2021-01-13 | — | — | EP | disclosed |
| EP-3753939-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | Array Biopharma Inc. (US) | 2020-12-23 | — | — | EP | disclosed |
| US-20200392130-A1 | SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-12-17 | — | — | US | disclosed |
| US-20200390760-A1 | PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | MERCK SHARP & DOHME CORP. (US) | 2020-12-17 | — | — | US | disclosed |
| WO-2020249791-A1 | SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2020-12-17 | — | — | WO | disclosed |
| EP-3727378-A1 | PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | Merck Sharp&Dohme Corp. (US) | 2020-10-28 | — | — | EP | disclosed |
| EP-3101013-B1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2020-10-21 | — | — | EP | disclosed |
| WO-2020210139-A1 | PYRAZOLESULFONAMIDES AS ANTITUMOR AGENTS | PELOTON THERAPEUTICS, INC. (US) | 2020-10-15 | — | — | WO | disclosed |
| EP-3720857-A1 | 2-OXO-5H-CHROMENO[4,3-B]PYRIDINES FOR USE IN THE TREATMENT OF HEPATITIS B | Galapagos NV (BE) | 2020-10-14 | — | — | EP | disclosed |
| US-20200317637-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LIMITED (IE) | 2020-10-08 | — | — | US | disclosed |
| US-20200308345-A1 | SELF-HEALING COPOLYMERIZED POLYCARBONATE AND PREPARATION METHOD THEREFOR | PUYANG SHENGTONGJUYUAN ADVANCED MATERIALS CO., LTD. (CN) | 2020-10-01 | — | — | US | disclosed |
| EP-3707134-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | Inflazome Limited (IE) | 2020-09-16 | — | — | EP | disclosed |
| US-20200270252-A1 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | NOVARTIS AG (CH) | 2020-08-27 | — | — | US | disclosed |
| CN-111448197-A | 2-oxo-5H-benzopyrano [4,3-b ] pyridines for the treatment of hepatitis B | 加拉帕戈斯股份有限公司 | 2020-07-24 | — | — | CN | disclosed |
| US-10703748-B2 | Diazanaphthalen-3-yl carboxamides and preparation and use thereof | SAMUMED, LLC (US) | 2020-07-07 | — | — | US | disclosed |
| CN-111315733-A | Novel sulfonamide carboxamide compounds | 英夫拉索姆有限公司 | 2020-06-19 | — | — | CN | disclosed |
| EP-3523301-B1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC (US) | 2020-05-27 | — | — | EP | disclosed |
| US-20200155531-A1 | Fumarate Analogs and Uses Thereof | MIDCAP FINANCIAL TRUST | 2020-05-21 | — | — | US | disclosed |
| US-20200109129-A1 | NEW 6-MEMBERED HETEROAROMATIC SUBSTITUTED CYANOINDOLINE DERIVATIVES AS NIK INHIBITORS | JANSSEN-CILAG (FR) | 2020-04-09 | — | — | US | disclosed |
| EP-3085694-B1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2020-03-25 | — | — | EP | disclosed |
| EP-3098218-B1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2020-03-25 | — | — | EP | disclosed |
| EP-3088395-B1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2020-03-25 | — | — | EP | disclosed |
| WO-2020053654-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | NOVARTIS AG (CH) | 2020-03-19 | — | — | WO | disclosed |
| US-20200079772-A1 | ANTIVIRAL PYRIDOPYRAZINEDIONE COMPOUNDS | NOVARTIS AG (CH) | 2020-03-12 | — | — | US | disclosed |
| EP-2900657-B1 | CYCLIC ETHER PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | HOFFMANN LA ROCHE (CH) | 2020-03-11 | — | — | EP | disclosed |
| EP-3615533-A1 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | Novartis AG (CH) | 2020-03-04 | — | — | EP | disclosed |
| EP-3085696-B1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2020-03-04 | — | — | EP | disclosed |
| CN-110845680-A | Energy-curable epoxy graft-modified amino resin, energy-curable composition containing same, and application | 常州强力电子新材料股份有限公司 | 2020-02-28 | — | — | CN | disclosed |
| CN-110845628-A | Energy-curable epoxy graft-modified cellulose nitrate, energy-curable composition containing same, and application | 常州强力电子新材料股份有限公司 | 2020-02-28 | — | — | CN | disclosed |
| CN-110845736-A | Energy-curable epoxy graft-modified silicone resins, energy-curable compositions containing the same, and applications | 常州强力电子新材料股份有限公司 | 2020-02-28 | — | — | CN | disclosed |
| CN-110845702-A | Energy-curable hyperbranched epoxy resin, energy-curable composition containing same and application | 常州强力电子新材料股份有限公司 | 2020-02-28 | — | — | CN | disclosed |
| EP-3252050-B1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2020-02-26 | — | — | EP | disclosed |
| EP-3252050-B1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2020-02-26 | — | — | EP | disclosed |
| CN-110831942-A | Fused indazolopyridinone compounds as antiviral agents | 诺华股份有限公司 | 2020-02-21 | — | — | CN | disclosed |
| WO-2020030924-A1 | THIAZOLEUREAS AS ANTICANCER AGENTS | ARTIOS PHARMA LIMITED (GB) | 2020-02-13 | — | — | WO | disclosed |
| WO-2020031836-A1 | POLYMERIZABLE IONIC LIQUID, POLYMER, CURABLE COMPOSITION, ELECTROCHEMICAL ELEMENT MATERIAL, AND ANTISTATIC MATERIAL | セントラル硝子株式会社 | 2020-02-13 | — | — | WO | disclosed |
| WO-2020030925-A1 | HETEROCYCLIC SUBSTITUTED UREAS, FOR USE AGAINST CANCER | ARTIOS PHARMA LIMITED (GB) | 2020-02-13 | — | — | WO | disclosed |
| US-20200048194-A1 | SUBSTITUTED BENZAMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2020-02-13 | — | — | US | disclosed |
| US-10555944-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | ELI LILLY AND COMPANY (US) | 2020-02-11 | — | — | US | disclosed |
| CN-110713593-A | Epoxy modified polyester resin, preparation method thereof, composition containing epoxy modified polyester resin and application thereof | 常州强力电子新材料股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-110713594-A | Epoxy modified alkyd resin, preparation method thereof, composition containing epoxy modified alkyd resin and application of composition | 常州强力电子新材料股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-110713580-A | Epoxy modified phenolic resin, preparation method thereof, composition containing epoxy modified phenolic resin and application thereof | 常州强力电子新材料股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-110713763-A | Energy-curable acrylic resin composition and use thereof | 常州强力电子新材料股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-110713797-A | Epoxy grafted rosin, preparation method thereof, composition containing epoxy grafted rosin and application of composition | 常州强力电子新材料股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| CN-110713561-A | Epoxy modified acrylic resin and preparation method thereof | 常州强力电子新材料股份有限公司 | 2020-01-21 | — | — | CN | disclosed |
| WO-2020011062-A1 | EPOXY MODIFIED ACRYLIC RESIN AND PREPARATION METHOD THEREFOR, AND ENERGY-CURABLE COMPOSITION CONTAINING EPOXY MODIFIED ACRYLIC RESIN AND APPLICATION | 常州强力电子新材料股份有限公司 | 2020-01-16 | — | — | WO | disclosed |
| CN-107074864-B | Triazolo [4, 5-d ] pyrimidines as agonists of cannabinoid receptor 2 | 豪夫迈·罗氏有限公司 | 2019-12-27 | — | — | CN | disclosed |
| EP-3119775-B1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | HOFFMANN LA ROCHE (CH) | 2019-11-06 | — | — | EP | disclosed |
| US-10457669-B2 | Benzolactam compounds as protein kinase inhibitors | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-10-29 | — | — | US | disclosed |
| CN-110382496-A | For treating substituted pyrido [3,4-b] indoles of cartilage disorder | 赛诺菲 | 2019-10-25 | — | — | CN | disclosed |
| CN-110382494-A | Substituted pyrazolo [1,5-A ] pyridine compounds as RET kinase inhibitors | 阿雷生物药品公司 | 2019-10-25 | — | — | CN | disclosed |
| US-20190300530-A1 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | NOVARTIS AG (CH) | 2019-10-03 | — | — | US | disclosed |
| CN-106573927-B | Oxyclohepten-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | 豪夫迈·罗氏有限公司 | 2019-09-27 | — | — | CN | disclosed |
| EP-3538516-A1 | PHENOXYTRIAZOLES | F. Hoffmann-La Roche AG (CH) | 2019-09-18 | — | — | EP | disclosed |
| EP-3180344-B1 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES USEFUL FOR INHIBITING JANUS KINASE | PFIZER (US) | 2019-09-18 | — | — | EP | disclosed |
| CN-109134537-B | The method for preparing the oxetanes based compound of TPO based compound co-production 3- hydroxyalkyl substitution | 湖北固润科技股份有限公司 | 2019-09-06 | — | — | CN | disclosed |
| US-10385026-B2 | Phthalazinones and isoquinolinones as rock inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-08-20 | — | — | US | disclosed |
| EP-3523301-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | Array Biopharma Inc. (US) | 2019-08-14 | — | — | EP | disclosed |
| CN-109942802-A | Copolymerization polycarbonate and preparation method thereof with self-repair function | 北京濮源新材料技术研究院(普通合伙) | 2019-06-28 | — | — | CN | disclosed |
| US-20190183886-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2019-06-20 | — | — | US | disclosed |
| WO-2019110352-A1 | 2-OXO-5H-CHROMENO[4,3-B]PYRIDINES FOR USE IN THE TREATMENT OF HEPATITIS B | GALAPAGOS NV (BE) | 2019-06-13 | — | — | WO | disclosed |
| US-10316028-B2 | Orexin receptor antagonists | HEPTARES THERAPEUTICS LIMITED (GB) | 2019-06-11 | — | — | US | disclosed |
| US-10301312-B2 | Fused indazole pyridone compounds as antivirals | NOVARTIS AG (CH) | 2019-05-28 | — | — | US | disclosed |
| CN-109790149-A | PHENOXYTRIAZOLES | 豪夫迈·罗氏有限公司 | 2019-05-21 | — | — | CN | disclosed |
| US-20190127370-A1 | DIAZANAPHTHALEN-3-YL CARBOXAMIDES AND PREPARATION AND USE THEREOF | VICKERS-SPLICE CO-INVESTMENT LLC (KY) | 2019-05-02 | — | — | US | disclosed |
| EP-3235016-B1 | A FERROELECTRIC ADHESIVE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2019-04-17 | — | — | EP | disclosed |
| US-RE47334-E1 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-20190047990-A1 | BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
| US-10183946-B2 | Triazolo[4,5-D]pyrimidines | HOFFMANN-LA ROCHE INC. (US) | 2019-01-22 | — | — | US | disclosed |
| EP-3423435-A1 | SUBSTITUTED INDOLE MCL-1 INHIBITORS | Vanderbilt University (US) | 2019-01-09 | — | — | EP | disclosed |
| US-10172851-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2019-01-08 | — | — | US | disclosed |
| CN-109134537-A | The method for preparing the oxetanes based compound of TPO based compound co-production 3- hydroxyalkyl substitution | 湖北固润科技股份有限公司 | 2019-01-04 | — | — | CN | disclosed |
| EP-3215506-B1 | TRIAZOLO[4,5-D]PYRIMIDINES AS AGONISTS OF THE CANNABINOID RECEPTOR 2 | HOFFMANN LA ROCHE (CH) | 2019-01-02 | — | — | EP | disclosed |
| US-20180370961-A1 | OREXIN RECEPTOR ANTAGONISTS | NXERA PHARMA UK LIMITED (GB) | 2018-12-27 | — | — | US | disclosed |
| US-10160748-B2 | Indazolones as modulators of tnf signaling | ABBVIE INC. (US) | 2018-12-25 | — | — | US | disclosed |
| US-10137124-B2 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2018-11-27 | — | — | US | disclosed |
| CN-104640858-B | Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | 霍夫曼-拉罗奇有限公司 | 2018-11-06 | — | — | CN | disclosed |
| US-20180312507-A1 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | NOVARTIS AG (CH) | 2018-11-01 | — | — | US | disclosed |
| WO-2018198079-A1 | FUSED INDAZOLE PYRIDONE COMPOUNDS AS ANTIVIRALS | NOVARTIS AG (CH) | 2018-11-01 | — | — | WO | disclosed |
| US-10112942-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | ARRAY BIOPHARMA INC. (US) | 2018-10-30 | — | — | US | disclosed |
| CN-104418866-B | Dgat1 inhibitor and its preparation method and application | 青岛黄海制药有限责任公司 | 2018-10-16 | — | — | CN | disclosed |
| US-20180162823-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-06-14 | — | — | US | disclosed |
| US-20180162823-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-06-14 | — | — | US | disclosed |
| EP-2945943-B1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-05-30 | — | — | EP | disclosed |
| EP-2945943-B1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-05-30 | — | — | EP | disclosed |
| US-20180133213-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2018-05-17 | — | — | US | disclosed |
| WO-2018087018-A1 | PHENOXYTRIAZOLES | F. HOFFMANN-LA ROCHE AG (CH) | 2018-05-17 | — | — | WO | disclosed |
| US-20180133200-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2018-05-17 | — | — | US | disclosed |
| US-20180134702-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ARRAY BIOPHARMA INC. | 2018-05-17 | — | — | US | disclosed |
| US-9963446-B2 | Oxepan-2-yl-pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | GENENTECH, INC. (US) | 2018-05-08 | — | — | US | disclosed |
| WO-2018075698-A1 | OXYSTEROLS AND METHODS OF USE THEREOF | SAGE THERAPEUTICS, INC. (US) | 2018-04-26 | — | — | WO | disclosed |
| WO-2018071447-A1 | SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | ANDREWS STEVEN W (US) | 2018-04-19 | — | — | WO | disclosed |
| US-9931323-B2 | Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | GENENTECH, INC. (US) | 2018-04-03 | — | — | US | disclosed |
| US-20180086737-A1 | INDAZOLONES AS MODULATORS OF TNF SIGNALING | ABBVIE INC. | 2018-03-29 | — | — | US | disclosed |
| US-9926282-B2 | Phthalazinones and isoquinolinones as rock inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-03-27 | — | — | US | disclosed |
| US-9926282-B2 | Phthalazinones and isoquinolinones as rock inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-03-27 | — | — | US | disclosed |
| US-9920018-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-9920018-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2018-03-20 | — | — | US | disclosed |
| US-20180071271-A1 | Fumarate Analogs and Uses Thereof | MIDCAP FINANCIAL TRUST | 2018-03-15 | — | — | US | disclosed |
| US-20180071271-A1 | Fumarate Analogs and Uses Thereof | MIDCAP FINANCIAL TRUST | 2018-03-15 | — | — | US | disclosed |
| EP-3092234-B1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2018-02-14 | — | — | EP | disclosed |
| EP-3092234-B1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2018-02-14 | — | — | EP | disclosed |
| US-9850237-B2 | Orexin receptor antagonists | HEPTARES THERAPEUTICS LIMITED (GB) | 2017-12-26 | — | — | US | disclosed |
| US-20170349544-A1 | Ethynylbenzene Derivatives | DUKE UNIVERSITY | 2017-12-07 | — | — | US | disclosed |
| US-20170349544-A1 | Ethynylbenzene Derivatives | DUKE UNIVERSITY | 2017-12-07 | — | — | US | disclosed |
| EP-3252049-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-12-06 | — | — | EP | disclosed |
| EP-3252049-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-12-06 | — | — | EP | disclosed |
| EP-3252050-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-12-06 | — | — | EP | disclosed |
| EP-3252050-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Bristol-Myers Squibb Company (US) | 2017-12-06 | — | — | EP | disclosed |
| CN-107438648-A | A kind of ferroelectricity adhesive composition | 汉高股份有限及两合公司 | 2017-12-05 | — | — | CN | disclosed |
| US-9809604-B2 | DGAT1 inhibitor and preparation method and use thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD. (CN) | 2017-11-07 | — | — | US | disclosed |
| US-9809604-B2 | DGAT1 inhibitor and preparation method and use thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD. (CN) | 2017-11-07 | — | — | US | disclosed |
| US-9809604-B2 | DGAT1 inhibitor and preparation method and use thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD. (CN) | 2017-11-07 | — | — | US | disclosed |
| US-9801866-B2 | Fumarate analogs and uses thereof | Rigl Pharmaceutical, Inc. (US) | 2017-10-31 | — | — | US | disclosed |
| US-9801866-B2 | Fumarate analogs and uses thereof | Rigl Pharmaceutical, Inc. (US) | 2017-10-31 | — | — | US | disclosed |
| US-9801866-B2 | Fumarate analogs and uses thereof | Rigl Pharmaceutical, Inc. (US) | 2017-10-31 | — | — | US | disclosed |
| US-20170306190-A1 | FERROELECTRIC ADHESIVE COMPOSITION | Henkel IP & Holding GmbH (DE) | 2017-10-26 | — | — | US | disclosed |
| EP-3235016-A1 | A FERROELECTRIC ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2017-10-25 | — | — | EP | disclosed |
| EP-3215506-A1 | TRIAZOLO[4,5-D]PYRIMIDINES AS AGONISTS OF THE CANNABINOID RECEPTOR 2 | F. Hoffmann-La Roche AG (CH) | 2017-09-13 | — | — | EP | disclosed |
| US-9738604-B2 | Ethynylbenzene derivatives | DUKE UNIVERSITY (US) | 2017-08-22 | — | — | US | disclosed |
| US-9738604-B2 | Ethynylbenzene derivatives | DUKE UNIVERSITY (US) | 2017-08-22 | — | — | US | disclosed |
| US-20170204103-A1 | NOVEL TRIAZOLO[4,5-D]PYRIMIDINES | HOFFMANN-LA ROCHE INC. (US) | 2017-07-20 | — | — | US | disclosed |
| EP-3187490-A1 | SUBSTITUTED BENZAMIDE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2017-07-05 | — | — | EP | disclosed |
| EP-3180344-A1 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES USEFUL FOR INHIBITING JANUS KINASE | Pfizer Inc (US) | 2017-06-21 | — | — | EP | disclosed |
| EP-3177599-A1 | FUMARATE ANALOGS AND USES THEREOF IN THE TREATMENT OF AN AUTOIMMUNE DISEASE OR AN INFLAMMATORY DISEASE | Rigel Pharmaceuticals, Inc. (US) | 2017-06-14 | — | — | EP | disclosed |
| US-9676760-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-9676760-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-9676760-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2017-06-13 | — | — | US | disclosed |
| US-20170121320-A1 | OREXIN RECEPTOR ANTAGONISTS | NXERA PHARMA UK LIMITED (GB) | 2017-05-04 | — | — | US | disclosed |
| EP-2870144-B1 | OREXIN RECEPTOR ANTAGONISTS | HEPTARES THERAPEUTICS LTD (GB) | 2017-04-19 | — | — | EP | disclosed |
| US-20170088527-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2017-03-30 | — | — | US | disclosed |
| US-20170088527-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2017-03-30 | — | — | US | disclosed |
| US-20170088527-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2017-03-30 | — | — | US | disclosed |
| US-9598435-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2017-03-21 | — | — | US | disclosed |
| US-9598435-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2017-03-21 | — | — | US | disclosed |
| US-9598435-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2017-03-21 | — | — | US | disclosed |
| US-20170065569-A1 | Fumarate Analogs and Uses Thereof | MIDCAP FINANCIAL TRUST | 2017-03-09 | — | — | US | disclosed |
| US-20170065569-A1 | Fumarate Analogs and Uses Thereof | MIDCAP FINANCIAL TRUST | 2017-03-09 | — | — | US | disclosed |
| US-20170065569-A1 | Fumarate Analogs and Uses Thereof | MIDCAP FINANCIAL TRUST | 2017-03-09 | — | — | US | disclosed |
| EP-2861604-B1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | GILEAD SCIENCES INC (US) | 2017-03-01 | — | — | EP | disclosed |
| EP-2861604-B1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | GILEAD SCIENCES INC (US) | 2017-03-01 | — | — | EP | disclosed |
| CN-103857659-B | Fused benzoxazepines as modulators of ion channels | 吉利德科学公司 | 2017-02-15 | — | — | CN | disclosed |
| US-9555044-B2 | Orexin receptor antagonists | HEPTARES THERAPEUTICS LIMITED (GB) | 2017-01-31 | — | — | US | disclosed |
| EP-3119775-A1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2017-01-25 | — | — | EP | disclosed |
| US-20170001997-A1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2017-01-05 | — | — | US | disclosed |
| EP-3101013-A1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | Gilead Sciences, Inc. (US) | 2016-12-07 | — | — | EP | disclosed |
| US-9512175-B2 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-9512175-B2 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-9512175-B2 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2016-12-06 | — | — | US | disclosed |
| US-20160347744-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-12-01 | — | — | US | disclosed |
| US-20160347744-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-12-01 | — | — | US | disclosed |
| US-20160347744-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-12-01 | — | — | US | disclosed |
| EP-3098218-A1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | Gilead Sciences, Inc. (US) | 2016-11-30 | — | — | EP | disclosed |
| US-9505746-B2 | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | GENENTECH, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| EP-2379636-B1 | COATING OF HYDROXYLATED SURFACES BY GAS PHASE GRAFTING | CARLSBERG AS (DK) | 2016-11-23 | — | — | EP | disclosed |
| EP-3092234-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | Gilead Sciences, Inc. (US) | 2016-11-16 | — | — | EP | disclosed |
| US-20160317504-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-11-03 | — | — | US | disclosed |
| US-20160317504-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-11-03 | — | — | US | disclosed |
| US-20160317504-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-11-03 | — | — | US | disclosed |
| EP-3088395-A1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | Gilead Sciences, Inc. (US) | 2016-11-02 | — | — | EP | disclosed |
| EP-3085696-A1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | Gilead Sciences, Inc. (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-3085694-A1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | Gilead Sciences, Inc. (US) | 2016-10-26 | — | — | EP | disclosed |
| US-9475781-B2 | Fumarate analogs and uses thereof | RIGEL PHARMACEUTICALS, INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-9475781-B2 | Fumarate analogs and uses thereof | RIGEL PHARMACEUTICALS, INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-9475781-B2 | Fumarate analogs and uses thereof | RIGEL PHARMACEUTICALS, INC. (US) | 2016-10-25 | — | — | US | disclosed |
| US-20160304496-A1 | INDAZOLONES AS MODULATORS OF TNF SIGNALING | ABBVIE INC. | 2016-10-20 | — | — | US | disclosed |
| US-9452980-B2 | Substituted benzamides | HOFFMANN-LA ROCHE INC. (US) | 2016-09-27 | — | — | US | disclosed |
| US-20160272651-A1 | DGAT1 Inhibitor and Preparation Method and Use Thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD. (CN) | 2016-09-22 | — | — | US | disclosed |
| US-20160272651-A1 | DGAT1 Inhibitor and Preparation Method and Use Thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD. (CN) | 2016-09-22 | — | — | US | disclosed |
| US-20160272651-A1 | DGAT1 Inhibitor and Preparation Method and Use Thereof | QINGDAO HUANGHAI PHARMACEUTICAL CO., LTD. (CN) | 2016-09-22 | — | — | US | disclosed |
| CN-103820129-B | Aligning agent for liquid crystal, liquid crystal orientation film and forming method thereof, the phase retardation film of liquid crystal display cells and liquid crystal cells | JSR株式会社 | 2016-09-21 | — | — | CN | disclosed |
| US-20160264596-A1 | SUBSTITUTED BENZAMIDES | HOFFMANN-LA ROCHE INC. | 2016-09-15 | — | — | US | disclosed |
| US-9434743-B2 | Indazole derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-09-06 | — | — | US | disclosed |
| US-9428635-B2 | Coating of hydroxylated surfaces by gas phase grafting | CARLSBERG A/S (DK) | 2016-08-30 | — | — | US | disclosed |
| US-9428635-B2 | Coating of hydroxylated surfaces by gas phase grafting | CARLSBERG A/S (DK) | 2016-08-30 | — | — | US | disclosed |
| US-9428635-B2 | Coating of hydroxylated surfaces by gas phase grafting | CARLSBERG A/S (DK) | 2016-08-30 | — | — | US | disclosed |
| US-9421136-B2 | Absorbent article comprising a contraphilic polymer | SCA HYGIENE PRODUCTS AB (SE) | 2016-08-23 | — | — | US | disclosed |
| US-9416115-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCINECES, INC. (US) | 2016-08-16 | — | — | US | disclosed |
| CN-105829303-A | Fused heterocyclic compounds as modulators of ion channels | 吉利德科学公司 | 2016-08-03 | — | — | CN | disclosed |
| US-20160213678-A1 | OREXIN RECEPTOR ANTAGONISTS | NXERA PHARMA UK LIMITED (GB) | 2016-07-28 | — | — | US | disclosed |
| US-20160213652-A1 | Cyclic Ether Pyrazol-4-YL-Heterocyclyl-Carboxamide Compounds And Methods Of Use | GENENTECH, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| EP-3042907-A1 | DGAT1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF | Medshine Discovery Inc. (CN) | 2016-07-13 | — | — | EP | disclosed |
| WO-2016097077-A1 | A FERROELECTRIC ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2016-06-23 | — | — | WO | disclosed |
| EP-2831053-B1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2016-06-22 | — | — | EP | disclosed |
| EP-2831053-B1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2016-06-22 | — | — | EP | disclosed |
| EP-2726466-B1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | GILEAD SCIENCES INC (US) | 2016-05-25 | — | — | EP | disclosed |
| WO-2016071375-A1 | TRIAZOLO[4,5-D]PYRIMIDINES AS AGONISTS OF THE CANNABINOID RECEPTOR 2 | F. HOFFMANN-LA ROCHE AG (CH) | 2016-05-12 | — | — | WO | disclosed |
| US-9328106-B2 | Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | GENENTECH, INC. (US) | 2016-05-03 | — | — | US | disclosed |
| US-20160096846-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-04-07 | — | — | US | disclosed |
| US-20160096846-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-04-07 | — | — | US | disclosed |
| US-20160096846-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2016-04-07 | — | — | US | disclosed |
| EP-2563770-B1 | BIARYL PHOSPHODIESTERASE INHIBITORS | LEO PHARMA AS (DK) | 2016-03-23 | — | — | EP | disclosed |
| US-20160045508-A1 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES | PFIZER INC. (US) | 2016-02-18 | — | — | US | disclosed |
| WO-2016024185-A1 | PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES USEFUL FOR INHIBITING JANUS KINASE | PFIZER INC. (US) | 2016-02-18 | — | — | WO | disclosed |
| EP-2831064-B1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2016-02-17 | — | — | EP | disclosed |
| EP-2831064-B1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2016-02-17 | — | — | EP | disclosed |
| WO-2016022434-A1 | FUMARATE ANALOGS AND USES THEREOF IN THE TREATMENT OF AN AUTOIMMUNE DISEASE OR AN INFLAMMATORY DISEASE | RIGEL PHARMACEUTICALS, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
| WO-2016022434-A1 | FUMARATE ANALOGS AND USES THEREOF IN THE TREATMENT OF AN AUTOIMMUNE DISEASE OR AN INFLAMMATORY DISEASE | RIGEL PHARMACEUTICALS, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
| US-20160039773-A1 | FUMARATE ANALOGS AND USES THEREOF | MIDCAP FINANCIAL TRUST | 2016-02-11 | — | — | US | disclosed |
| US-9249160-B2 | Orexin receptor antagonists | HEPTARES THERAPEUTICS LIMITED (GB) | 2016-02-02 | — | — | US | disclosed |
| US-20150353505-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-20150353505-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-20150353505-A1 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-20150344521-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | CYPRALIS LIMITED (GB) | 2015-12-03 | — | — | US | disclosed |
| US-20150344521-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | CYPRALIS LIMITED (GB) | 2015-12-03 | — | — | US | disclosed |
| US-20150344521-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | CYPRALIS LIMITED (GB) | 2015-12-03 | — | — | US | disclosed |
| EP-2945943-A2 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | Bristol-Myers Squibb Company (US) | 2015-11-25 | — | — | EP | disclosed |
| US-9193694-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2015-11-24 | — | — | US | disclosed |
| US-9145441-B2 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-9145441-B2 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-9145441-B2 | Macrocyclic inhibitors of flaviviridae viruses | GILEAD SCIENCES, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| WO-2015140189-A1 | OXEPAN-2-YL-PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2015-09-24 | — | — | WO | disclosed |
| EP-2900657-A1 | CYCLIC ETHER PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. Hoffmann-La Roche AG (CH) | 2015-08-05 | — | — | EP | disclosed |
| WO-2015094670-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2015-06-25 | — | — | WO | disclosed |
| US-20150175560-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2015-06-25 | — | — | US | disclosed |
| US-9051290-B2 | Biaryl phosphodiesterase inhibitors | LEO PHARMA A/S (DK) | 2015-06-09 | — | — | US | disclosed |
| EP-2870144-A1 | OREXIN RECEPTOR ANTAGONISTS | Heptares Therapeutics Limited (GB) | 2015-05-13 | — | — | EP | disclosed |
| US-20150126498-A1 | OREXIN RECEPTOR ANTAGONISTS | NXERA PHARMA UK LIMITED (GB) | 2015-05-07 | — | — | US | disclosed |
| EP-2861604-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | Gilead Sciences, Inc. (US) | 2015-04-22 | — | — | EP | disclosed |
| US-9012446-B2 | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2015-04-21 | — | — | US | disclosed |
| EP-2831064-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2015-02-04 | — | — | EP | disclosed |
| EP-2831053-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2015-02-04 | — | — | EP | disclosed |
| CN-104321464-A | Selective coating of exposed copper on silver-plated copper | HENKEL CORP | 2015-01-28 | — | — | CN | disclosed |
| EP-2826772-A1 | Intermediates for the synthesis of oxygen-substituted 3-heteroaroylamino-propionic acid derivatives | SANOFI (FR) | 2015-01-21 | — | — | EP | disclosed |
| US-20150005232-A1 | INDAZOLE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (US) | 2015-01-01 | — | — | US | disclosed |
| EP-2528902-B1 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2014-11-12 | — | — | EP | disclosed |
| US-8883782-B2 | Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-20140295200-A1 | SELECTIVE COATING OF EXPOSED COPPER ON SILVER-PLATED COPPER | Henkel IP & Holding GmbH (DE) | 2014-10-02 | — | — | US | disclosed |
| EP-2760857-A1 | PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F.HOFFMANN-LA ROCHE AG (CH) | 2014-08-06 | — | — | EP | disclosed |
| WO-2014113620-A2 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-07-24 | — | — | WO | disclosed |
| WO-2014113620-A2 | PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2014-07-24 | — | — | WO | disclosed |
| US-20140135317-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140135317-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140135317-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2014-05-15 | — | — | US | disclosed |
| US-20140128616-A1 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2014-05-08 | — | — | US | disclosed |
| EP-2726466-A1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | Gilead Sciences, Inc. (US) | 2014-05-07 | — | — | EP | disclosed |
| EP-2440521-B1 | NOVEL CYCLOPENTANE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2014-04-30 | — | — | EP | disclosed |
| US-8697863-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2014-04-15 | — | — | US | disclosed |
| US-20140088117-A1 | CYCLIC ETHER PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2014-03-27 | — | — | US | disclosed |
| US-8678090-B2 | Methods for treating hydrocarbon-bearing formations with fluorinated polymer compositions | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-03-25 | — | — | US | disclosed |
| US-20140080801-A1 | PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2014-03-20 | — | — | US | disclosed |
| US-8664257-B2 | Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals | SANOFI (FR) | 2014-03-04 | — | — | US | disclosed |
| US-20140045828-A1 | AMINO-OXAZINES AND AMINO-DIHYDROTHIAZINE COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE | AMGEN INC. | 2014-02-13 | — | — | US | disclosed |
| US-8642585-B2 | Indanyloxydihydrobenzofuranylacetic acids | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-02-04 | — | — | US | disclosed |
| US-8642585-B2 | Indanyloxydihydrobenzofuranylacetic acids | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-02-04 | — | — | US | disclosed |
| US-8642585-B2 | Indanyloxydihydrobenzofuranylacetic acids | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-02-04 | — | — | US | disclosed |
| US-20140030221-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | CYPRALIS LIMITED (GB) | 2014-01-30 | — | — | US | disclosed |
| US-20140030221-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | CYPRALIS LIMITED (GB) | 2014-01-30 | — | — | US | disclosed |
| US-20140030221-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | CYPRALIS LIMITED (GB) | 2014-01-30 | — | — | US | disclosed |
| EP-2547686-B1 | AMINO-DIHYDROOXAZINE AND AMINO-DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA-SECRETASE MODULATORS AND THEIR MEDICAL USE | AMGEN INC (US) | 2014-01-22 | — | — | EP | disclosed |
| WO-2014006402-A1 | OREXIN RECEPTOR ANTAGONISTS | HEPTARES THERAPEUTICS LIMITED (GB) | 2014-01-09 | — | — | WO | disclosed |
| EP-1927592-B1 | Oxetane-containing compound, photoresist composition having the same, method of preparing pattern using the photoresist composition, and inkjet print head including polymerization products of the oxetane-containing compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2014-01-01 | — | — | EP | disclosed |
| EP-1927592-B1 | Oxetane-containing compound, photoresist composition having the same, method of preparing pattern using the photoresist composition, and inkjet print head including polymerization products of the oxetane-containing compound | SAMSUNG ELECTRONICS CO LTD (KR) | 2014-01-01 | — | — | EP | disclosed |
| US-8614206-B2 | Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use | F. HOFFMANN-LA ROCHE AG (CH) | 2013-12-24 | — | — | US | disclosed |
| WO-2013185103-A1 | MACROCYCLIC INHIBITORS OF FLAVIVIRIDAE VIRUSES | GILEAD SCIENCES, INC. (US) | 2013-12-12 | — | — | WO | disclosed |
| US-8586732-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-8586732-B2 | Fused heterocyclic compounds as ion channel modulators | GILEAD SCIENCES, INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-8569281-B2 | Compounds and their administration for treating a neurodegenerative disease as well as a method for identifying a compound capable of inhibiting a kinase, such as LRRK | MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) | 2013-10-29 | — | — | US | disclosed |
| WO-2013144098-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013144097-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013144097-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013144098-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACID DERIVATIVES AND THEIR USE AS GPR40 RECEPTOR AGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-10-03 | — | — | WO | disclosed |
| US-20130252937-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20130252937-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| US-20130252937-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2013-09-26 | — | — | US | disclosed |
| WO-2013130855-A1 | INDAZOLE DERIVATIVES | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-09-06 | — | — | WO | disclosed |
| US-20130231323-A1 | ETHYNYLBENZENE DERIVATIVES | DUKE UNIVERSITY (US) | 2013-09-05 | — | — | US | disclosed |
| US-20130231323-A1 | ETHYNYLBENZENE DERIVATIVES | DUKE UNIVERSITY (US) | 2013-09-05 | — | — | US | disclosed |
| EP-2619201-A1 | PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2 | Medical Research Council Technology (GB) | 2013-07-31 | — | — | EP | disclosed |
| US-8497264-B2 | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use | AMGEN INC. (US) | 2013-07-30 | — | — | US | disclosed |
| EP-2470546-B1 | HEXAHYDROOXAZINOPTERIDINE COMPOUNDS FOR USE AS MTOR INHIBITORS | TAKEDA PHARMACEUTICAL (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20130184255-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2013-07-18 | — | — | US | disclosed |
| US-20130184255-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2013-07-18 | — | — | US | disclosed |
| US-20130184255-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2013-07-18 | — | — | US | disclosed |
| WO-2013089816-A1 | SELECTIVE COATING OF EXPOSED COPPER ON SILVER-PLATED COPPER | HENKEL CORPORATION (US) | 2013-06-20 | — | — | WO | disclosed |
| WO-2013045461-A1 | PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-04-04 | — | — | WO | disclosed |
| US-20130079321-A1 | PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | GENENTECH, INC. (US) | 2013-03-28 | — | — | US | disclosed |
| US-20130059853-A1 | BIARYL PHOSPHODIESTERASE INHIBITORS | LEO PHARMA A/S (DK) | 2013-03-07 | — | — | US | disclosed |
| EP-2563770-A1 | BIARYL PHOSPHODIESTERASE INHIBITORS | Leo Pharma A/S (DK) | 2013-03-06 | — | — | EP | disclosed |
| US-20130046004-A1 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2013-02-21 | — | — | US | disclosed |
| US-20130035326-A1 | BIARYL COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2013-02-07 | — | — | US | disclosed |
| EP-2547686-A1 | AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE | Amgen Inc. (US) | 2013-01-23 | — | — | EP | disclosed |
| EP-2547685-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETA - SECRETASE MODULATORS | Amgen Inc. (US) | 2013-01-23 | — | — | EP | disclosed |
| US-20130012492-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2013-01-10 | — | — | US | disclosed |
| WO-2013006485-A1 | FUSED BENZOXAZEPINONES AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. (US) | 2013-01-10 | — | — | WO | disclosed |
| US-20130012492-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2013-01-10 | — | — | US | disclosed |
| US-20130012492-A1 | FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS | GILEAD SCIENCES, INC. | 2013-01-10 | — | — | US | disclosed |
| EP-2528902-A1 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2012-12-05 | — | — | EP | disclosed |
| US-20120295883-A1 | COMPOUNDS | GENENTECH, INC. (US) | 2012-11-22 | — | — | US | disclosed |
| EP-2516392-A1 | SUBSTITUTED BENZAMIDE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2012-10-31 | — | — | EP | disclosed |
| US-8268819-B2 | Hexahydrooxazinopterine compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-09-18 | — | — | US | disclosed |
| EP-1992654-B1 | Radiation- or thermally-curable oxetane barrier sealants | HENKEL AG & CO KGAA (DE) | 2012-09-12 | — | — | EP | disclosed |
| US-20120178924-A1 | HEXAHYDROOXAZINOPTERINE COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-07-12 | — | — | US | disclosed |
| EP-2470546-A1 | HEXAHYDROOXAZINOPTERINE COMPOUNDS FOR USE AS mTOR INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2012-07-04 | — | — | EP | disclosed |
| EP-2467137-A1 | BIARYL COMPOUNDS AND METHODS OF USE THEREOF | Ambit Biosciences Corporation (US) | 2012-06-27 | — | — | EP | disclosed |
| US-8163463-B2 | Photoresist composition, method of forming pattern using the photoresist composition and inkjet print head | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-04-24 | — | — | US | disclosed |
| US-8163755-B2 | Hexahydrooxazinopterine compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-2440521-A1 | NOVEL CYCLOPENTANE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2012-04-18 | — | — | EP | disclosed |
| WO-2012038743-A1 | PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2 | MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) | 2012-03-29 | — | — | WO | disclosed |
| WO-2012031298-A2 | ETHYNYLBENZENE DERIVATIVES | DUKE UNIVERSITY (US) | 2012-03-08 | — | — | WO | disclosed |
| EP-2240552-B1 | METHODS FOR TREATING HYDROCARBON-BEARING FORMATIONS WITH FLUORINATED POLYMER COMPOSITIONS | 3M INNOVATIVE PROPERTIES CO (US) | 2012-02-29 | — | — | EP | disclosed |
| US-20120040112-A1 | COATING OF HYDROXYLATED SURFACES BY GAS PHASE GRAFTING | CARLSBERG A/S (DK) | 2012-02-16 | — | — | US | disclosed |
| US-20120040112-A1 | COATING OF HYDROXYLATED SURFACES BY GAS PHASE GRAFTING | CARLSBERG A/S (DK) | 2012-02-16 | — | — | US | disclosed |
| US-20120040112-A1 | COATING OF HYDROXYLATED SURFACES BY GAS PHASE GRAFTING | CARLSBERG A/S (DK) | 2012-02-16 | — | — | US | disclosed |
| EP-2245023-B1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | HOFFMANN LA ROCHE (CH) | 2011-12-28 | — | — | EP | disclosed |
| US-8071797-B2 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC (US) | 2011-12-06 | — | — | US | disclosed |
| WO-2011134468-A1 | BIARYL PHOSPHODIESTERASE INHIBITORS | LEO PHARMA A/S (DK) | 2011-11-03 | — | — | WO | disclosed |
| EP-2379636-A2 | COATING OF HYDROXYLATED SURFACES BY GAS PHASE GRAFTING | Carlsberg A/S (DK) | 2011-10-26 | — | — | EP | disclosed |
| US-20110251190-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE | AMGEN INC. (US) | 2011-10-13 | — | — | US | disclosed |
| US-20110251186-A1 | Amino-Oxazines and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use | AMGEN INC. (US) | 2011-10-13 | — | — | US | disclosed |
| EP-1548062-B1 | OPTICAL MATERIAL CONTAINING PHOTOCURABLE FLUOROPOLYMER AND PHOTOCURABLE FLUORORESIN COMPOSITION | DAIKIN IND LTD (JP) | 2011-10-05 | — | — | EP | disclosed |
| WO-2011115928-A1 | AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE | AMGEN INC. (US) | 2011-09-22 | — | — | WO | disclosed |
| WO-2011115938-A1 | SPIRO-TETRACYCLIC RING COMPOUNDS AS BETA - SECRETASE MODULATORS | AMGEN INC. (US) | 2011-09-22 | — | — | WO | disclosed |
| WO-2011092187-A1 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI (FR) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011076678-A1 | SUBSTITUTED BENZAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-30 | — | — | WO | disclosed |
| US-20110152245-A1 | SUBSTITUTED BENZAMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-06-23 | — | — | US | disclosed |
| US-20110136704-A1 | Methods of Treating a Hydrocarbon-Bearing Formation, a Well Bore, and Particles | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2011-06-09 | — | — | US | disclosed |
| EP-1866360-B1 | RADIATION-OR THERMALLY-CURABLE OXETANE BARRIER SEALANTS | HENKEL AG & CO KGAA (DE) | 2011-05-25 | — | — | EP | disclosed |
| EP-2300558-A2 | METHODS OF TREATING A HYDROCARBON-BEARING FORMATION, A WELL BORE, AND PARTICLES | Board of Regents, The University of Texas System (US) | 2011-03-30 | — | — | EP | disclosed |
| US-7915524-B2 | Sealing agent for photoelectric conversion device and photoelectric conversion device using the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-03-29 | — | — | US | disclosed |
| US-7902305-B2 | Waterproof; adhesive bonding strength after curing; polyoxazolines; electrooptics | HENKEL AG & CO. KGAA (DE) | 2011-03-08 | — | — | US | disclosed |
| WO-2011025889-A1 | HEXAHYDROOXAZINOPTERINE COMPOUNDS FOR USE AS mTOR INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-03-03 | — | — | WO | disclosed |
| US-20110053921-A1 | HEXAHYDROOXAZINOPTERINE COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-03-03 | — | — | US | disclosed |
| WO-2011022473-A1 | BIARYL COMPOUNDS AND METHODS OF USE THEREOF | AMBIT BIOSCIENCES CORPORATION (US) | 2011-02-24 | — | — | WO | disclosed |
| US-7893099-B2 | Cyclopentane derivatives | HOFFMAN-LA ROCHE INC. (US) | 2011-02-22 | — | — | US | disclosed |
| US-7887716-B2 | An electrophoretic device sealed with a barrier seal in comprising a cationic photoinitiator and a curable oxetane compound; organic electronics; packaging; polyoxetanes; high crosslinking density; microcrystalline; encapsulation; moistureproof; fillers;adhesion; epoxy copolymers; protective coatings | HENKEL AG & CO. KGAA (DE) | 2011-02-15 | — | — | US | disclosed |
| WO-2010142650-A1 | NOVEL CYCLOPENTANE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-12-16 | — | — | WO | disclosed |
| US-20100317647-A1 | NOVEL CYCLOPENTANE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-12-16 | — | — | US | disclosed |
| CN-101910145-A | Heterocyclic antiviral compounds | HOFFMANN LA ROCHE | 2010-12-08 | — | — | CN | disclosed |
| US-7842388-B2 | Functional polymers via surface modifying agents | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-11-30 | — | — | US | disclosed |
| US-7842388-B2 | Functional polymers via surface modifying agents | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-11-30 | — | — | US | disclosed |
| US-7842388-B2 | Functional polymers via surface modifying agents | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-11-30 | — | — | US | disclosed |
| EP-1989186-B1 | HYDANTOIN BASED KINASE INHIBITORS | HOFFMANN LA ROCHE (CH) | 2010-11-17 | — | — | EP | disclosed |
| US-20100280473-A1 | Absorbent Article Comprising a Contraphilic Polymer | SCA HYGIENE PRODUCTS AB (SE) | 2010-11-04 | — | — | US | disclosed |
| EP-2245023-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2010-11-03 | — | — | EP | disclosed |
| US-20100270021-A1 | METHODS FOR TREATING HYDROCARBON-BEARING FORMATIONS WITH FLUORINATED POLYMER COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-10-28 | — | — | US | disclosed |
| EP-2240552-A1 | METHODS FOR TREATING HYDROCARBON-BEARING FORMATIONS WITH FLUORINATED POLYMER COMPOSITIONS | 3M Innovative Properties Company (US) | 2010-10-20 | — | — | EP | disclosed |
| EP-1931396-B1 | ABSORBENT ARTICLE COMPRISING A CONTRAPHILIC POLYMER | SCA HYGIENE PROD AB (SE) | 2010-08-11 | — | — | EP | disclosed |
| US-7771793-B2 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-08-10 | — | — | US | disclosed |
| US-7771793-B2 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-08-10 | — | — | US | disclosed |
| US-7771793-B2 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2010-08-10 | — | — | US | disclosed |
| WO-2010069330-A2 | COATING OF HYDROXYLATED SURFACES BY GAS PHASE GRAFTING | CARLSBERG A/S (DK) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010069330-A2 | COATING OF HYDROXYLATED SURFACES BY GAS PHASE GRAFTING | CARLSBERG A/S (DK) | 2010-06-24 | — | — | WO | disclosed |
| US-7671114-B2 | Adhesive of substituted oxirane or oxetane compound with silver-based, lead-free solder | HENKEL CORPORATION (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671114-B2 | Adhesive of substituted oxirane or oxetane compound with silver-based, lead-free solder | HENKEL CORPORATION (US) | 2010-03-02 | — | — | US | disclosed |
| US-7671114-B2 | Adhesive of substituted oxirane or oxetane compound with silver-based, lead-free solder | HENKEL CORPORATION (US) | 2010-03-02 | — | — | US | disclosed |
| EP-1389224-B1 | POLYMERIC SURFACTANTS DERIVED FROM CYCLIC MONOMERS HAVING PENDANT FLUORINATED CARBON GROUPS | OMNOVA SOLUTIONS INC (US) | 2010-01-13 | — | — | EP | disclosed |
| WO-2009148831-A2 | METHODS OF TREATING A HYDROCARBON-BEARING FORMATION, A WELL BORE, AND PARTICLES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-12-10 | — | — | WO | disclosed |
| US-7612212-B2 | 2-[(S)-2-((S)-2,5-dioxo-4-phenyl-imidazolidin-1-yl)-4-methyl-pentanoylamino]-thiazole-4-carboxylic acid methyl ester; mitogen activated protein/extracellular signal regulated kinase kinase inhibitor; anticarcinogenic agent, cognition activator, nervous and autoimmune system disorders | HOFFMANN-LA ROCHE INC. (US) | 2009-11-03 | — | — | US | disclosed |
| WO-2009101022-A1 | HETEROCYCLIC ANTIVIRAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-08-20 | — | — | WO | disclosed |
| US-20090208449-A1 | Heterocyclic antiviral compounds | ROCHE PALO ALTO LLC | 2009-08-20 | — | — | US | disclosed |
| WO-2009085904-A1 | METHODS FOR TREATING HYDROCARBON-BEARING FORMATIONS WITH FLUORINATED POLYMER COMPOSITIONS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-07-09 | — | — | WO | disclosed |
| US-7524610-B2 | Oxetane-containing compound, photoresist composition having the same, method of preparing pattern using the photoresist composition, and inkjet print head including polymerization products of the oxetane-containing compound | SAMSUNG ELECTRONICS CO., LTD (KR) | 2009-04-28 | — | — | US | disclosed |
| US-7524610-B2 | Oxetane-containing compound, photoresist composition having the same, method of preparing pattern using the photoresist composition, and inkjet print head including polymerization products of the oxetane-containing compound | SAMSUNG ELECTRONICS CO., LTD (KR) | 2009-04-28 | — | — | US | disclosed |
| US-7524610-B2 | Oxetane-containing compound, photoresist composition having the same, method of preparing pattern using the photoresist composition, and inkjet print head including polymerization products of the oxetane-containing compound | SAMSUNG ELECTRONICS CO., LTD (KR) | 2009-04-28 | — | — | US | disclosed |
| US-20090088506-A1 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING BOTH POLYOXIRANE AND POLYOXETANE BLOCKS | ALLIANT TECHSYSTEMS INC. (US) | 2009-04-02 | — | — | US | disclosed |
| US-20090075197-A1 | PHOTORESIST COMPOSITION, METHOD OF FORMING PATTERN USING THE PHOTORESIST COMPOSITION AND INKJET PRINT HEAD | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-03-19 | — | — | US | disclosed |
| EP-2023204-A2 | Photoresist composition, method of forming pattern using the photoresist composition and inkjet print head | Samsung Electronics Co., Ltd. (KR) | 2009-02-11 | — | — | EP | disclosed |
| US-20090018239-A1 | UNDERFILL ADHESIVES | HENKEL CORPORATION (US) | 2009-01-15 | — | — | US | disclosed |
| US-20080296159-A1 | RADIATION-OR THERMALLY-CURABLE OXETANE BARRIER SEALANTS | HENKEL CORPORATION (US) | 2008-12-04 | — | — | US | disclosed |
| WO-2008141323-A1 | POLYOXETANE COMPOSITIONS AND METHODS FOR THEIR PRODUCTION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2008-11-20 | — | — | WO | disclosed |
| EP-1992654-A1 | Radiation- or thermally-curable oxetane barrier sealants | National Starch and Chemical Investment Holding Corporation (US) | 2008-11-19 | — | — | EP | disclosed |
| US-7452943-B2 | Polymer compounds containing oxetane and styrenic functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-11-18 | — | — | US | disclosed |
| US-7452943-B2 | Polymer compounds containing oxetane and styrenic functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-11-18 | — | — | US | disclosed |
| US-7452943-B2 | Polymer compounds containing oxetane and styrenic functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-11-18 | — | — | US | disclosed |
| EP-1989186-A1 | HYDANTOIN BASED KINASE INHIBITORS | F.HOFFMANN-LA ROCHE AG (CH) | 2008-11-12 | — | — | EP | disclosed |
| US-20080272328-A1 | RADIATION-OR THERMALLY-CURABLE OXETANE BARRIER SEALANTS | HENKEL CORPORATION (US) | 2008-11-06 | — | — | US | disclosed |
| EP-1794209-B1 | POLYETHER POLYMER MATRIX | NOVO NORDISK AS (DK) | 2008-10-08 | — | — | EP | disclosed |
| US-20080213568-A1 | Polyether Polymer Matrix | VERSANATRUX A/S (DK) | 2008-09-04 | — | — | US | disclosed |
| WO-2008101840-A1 | COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-08-28 | — | — | WO | disclosed |
| US-20080207563-A1 | METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELLS | NIU HUIFENG | 2008-08-28 | — | — | US | disclosed |
| EP-1958943-A1 | Oxetane compounds containing styrenic functionality | National Starch and Chemical Investment Holding Corporation (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1958943-A1 | Oxetane compounds containing styrenic functionality | National Starch and Chemical Investment Holding Corporation (US) | 2008-08-20 | — | — | EP | disclosed |
| US-7396590-B2 | Soft block with repeat units that favor migration to a surface and repeat units with an activity of interest, and polymeric articles or coatings using same | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2008-07-08 | — | — | US | disclosed |
| EP-1931396-A1 | ABSORBENT ARTICLE COMPRISING A CONTRAPHILIC POLYMER | SCA Hygiene Products AB (SE) | 2008-06-18 | — | — | EP | disclosed |
| EP-1620488-B1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NAT STARCH CHEM INVEST (US) | 2008-06-18 | — | — | EP | disclosed |
| EP-1620488-B1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NAT STARCH CHEM INVEST (US) | 2008-06-18 | — | — | EP | disclosed |
| US-20080131787-A1 | OXETANE-CONTAINING COMPOUND, PHOTORESIST COMPOSITION HAVING THE SAME, METHOD OF PREPARING PATTERN USING THE PHOTORESIST COMPOSITION, AND INKJET PRINT HEAD INCLUDING POLYMERIZATION PRODUCTS OF THE OXETANE-CONTAINING COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-06-05 | — | — | US | disclosed |
| US-20080131787-A1 | OXETANE-CONTAINING COMPOUND, PHOTORESIST COMPOSITION HAVING THE SAME, METHOD OF PREPARING PATTERN USING THE PHOTORESIST COMPOSITION, AND INKJET PRINT HEAD INCLUDING POLYMERIZATION PRODUCTS OF THE OXETANE-CONTAINING COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-06-05 | — | — | US | disclosed |
| US-20080131787-A1 | OXETANE-CONTAINING COMPOUND, PHOTORESIST COMPOSITION HAVING THE SAME, METHOD OF PREPARING PATTERN USING THE PHOTORESIST COMPOSITION, AND INKJET PRINT HEAD INCLUDING POLYMERIZATION PRODUCTS OF THE OXETANE-CONTAINING COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-06-05 | — | — | US | disclosed |
| EP-1927592-A1 | Oxetane-containing compound, photoresist composition having the same, method of preparing pattern using the photoresist composition, and inkjet print head including polymerization products of the oxetane-containing compound | Samsung Electronics Co., Ltd. (KR) | 2008-06-04 | — | — | EP | disclosed |
| EP-1927592-A1 | Oxetane-containing compound, photoresist composition having the same, method of preparing pattern using the photoresist composition, and inkjet print head including polymerization products of the oxetane-containing compound | Samsung Electronics Co., Ltd. (KR) | 2008-06-04 | — | — | EP | disclosed |
| US-20080121845-A1 | Oxetane composition, associated method and article | GENERAL ELECTRIC COMPANY (US) | 2008-05-29 | — | — | US | disclosed |
| US-7354985-B2 | Fluorinated thermoset polyurethane elastomers prepared from polyether prepolymers formed from mono-substituted fluorinated oxetane monomers | AEROJET ROCKETDYNE, INC. (F/K/A AEROJET-GENERAL CORPORATION) | 2008-04-08 | — | — | US | disclosed |
| US-7354985-B2 | Fluorinated thermoset polyurethane elastomers prepared from polyether prepolymers formed from mono-substituted fluorinated oxetane monomers | AEROJET ROCKETDYNE, INC. (F/K/A AEROJET-GENERAL CORPORATION) | 2008-04-08 | — | — | US | disclosed |
| US-7354985-B2 | Fluorinated thermoset polyurethane elastomers prepared from polyether prepolymers formed from mono-substituted fluorinated oxetane monomers | AEROJET ROCKETDYNE, INC. (F/K/A AEROJET-GENERAL CORPORATION) | 2008-04-08 | — | — | US | disclosed |
| US-7354985-B2 | Fluorinated thermoset polyurethane elastomers prepared from polyether prepolymers formed from mono-substituted fluorinated oxetane monomers | AEROJET ROCKETDYNE, INC. (F/K/A AEROJET-GENERAL CORPORATION) | 2008-04-08 | — | — | US | disclosed |
| US-7348116-B2 | Aromatic heterocyclic-based charge transport materials having two amino groups | SAMSUNG ELECTRONICS, LTD (KR) | 2008-03-25 | — | — | US | disclosed |
| WO-2008021139-A1 | OXETANE COMPOSITION, ASSOCIATED METHOD AND ARTICLE | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2008021135-A2 | SYNERETIC COMPOSITION, ASSOCIATED METHOD AND ARTICLE | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2008019152-A1 | COMPOSITION, ASSOCIATED METHOD AND ARTICLE | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-02-14 | — | — | WO | disclosed |
| US-20080039608-A1 | Oxetane composition, associated method and article | GENERAL ELECTRIC COMPANY (US) | 2008-02-14 | — | — | US | disclosed |
| WO-2008019149-A1 | COMPOSITION AND ASSOCIATED METHOD | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-02-14 | — | — | WO | disclosed |
| WO-2008019151-A1 | OXETANE COMPOSITION, ASSOCIATED METHOD AND ARTICLE | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-02-14 | — | — | WO | disclosed |
| US-20080039560-A1 | Syneretic composition, associated method and article | GENERAL ELECTRIC COMPANY (US) | 2008-02-14 | — | — | US | disclosed |
| US-20080039542-A1 | Composition and associated method | GENERAL ELECTRIC COMPANY (US) | 2008-02-14 | — | — | US | disclosed |
| US-7320829-B2 | Fluorinated polymer and amine resin compositions and products formed therefrom | OMNOVA SOLUTIONS INC. (US) | 2008-01-22 | — | — | US | disclosed |
| US-7319132-B2 | Polymer compounds containing oxetane and maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319132-B2 | Polymer compounds containing oxetane and maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-01-15 | — | — | US | disclosed |
| US-7319132-B2 | Polymer compounds containing oxetane and maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2008-01-15 | — | — | US | disclosed |
| EP-1866360-A2 | RADIATION-OR THERMALLY-CURABLE OXETANE BARRIER SEALANTS | National Starch and Chemical Investment Holding Corporation (US) | 2007-12-19 | — | — | EP | disclosed |
| WO-2007096259-A1 | HYDANTOIN BASED KINASE INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-30 | — | — | WO | disclosed |
| US-20070197617-A1 | Substituted hydantoins | CHEN SHAOQING | 2007-08-23 | — | — | US | disclosed |
| EP-1794209-A1 | POLYETHER POLYMER MATRIX | VersaMatrix A/S (DK) | 2007-06-13 | — | — | EP | disclosed |
| WO-2007038965-A1 | ABSORBENT ARTICLE COMPRISING A CONTRAPHILIC POLYMER | SCA HYGIENE PRODUCTS AB (SE) | 2007-04-12 | — | — | WO | disclosed |
| US-20070034515-A1 | Radiation- or thermally-curable oxetane barrier sealants | HENKEL AG & CO. KGAA (DE) | 2007-02-15 | — | — | US | disclosed |
| EP-1736473-A2 | Oxetane compounds containing maleimide functionality | National Starch and Chemical Investment Holding Corporation (US) | 2006-12-27 | — | — | EP | disclosed |
| US-7148309-B2 | Amorphous polyether glycols based on bis-substituted oxetane monomers | AMPAC FINE CHEMICALS LLC (US) | 2006-12-12 | — | — | US | disclosed |
| EP-0811004-B1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET GENERAL CO (US) | 2006-12-06 | — | — | EP | disclosed |
| EP-0811004-B1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET GENERAL CO (US) | 2006-12-06 | — | — | EP | disclosed |
| EP-1297047-B1 | ANIONIC WATERBORNE POLYURETHANE DISPERSIONS CONTAINING POLYFLUOROOXETANES | OMNOVA SOLUTIONS INC (US) | 2006-11-15 | — | — | EP | disclosed |
| WO-2006107803-A2 | RADIATION-OR THERMALLY-CURABLE OXETANE BARRIER SEALANTS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2006-10-12 | — | — | WO | disclosed |
| US-20060223978-A1 | Radiation- or thermally-curable oxetane barrier sealants | HENKEL AG & CO. KGAA (DE) | 2006-10-05 | — | — | US | disclosed |
| US-7101955-B1 | Synthesis of energetic thermoplastic elastomers containing both polyoxirane and polyoxetane blocks | ALLIANT TECHSYSTEMS INC. (US) | 2006-09-05 | — | — | US | disclosed |
| US-20060194065-A1 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2006-08-31 | — | — | US | disclosed |
| EP-1689800-A1 | FLAME RETARDANT RADIATION CURABLE COMPOSITIONS | DSM IP Assets B.V. (NL) | 2006-08-16 | — | — | EP | disclosed |
| EP-1244727-B1 | MONOHYDRIC POLYFLUOROOXETANE OLIGOMERS, POLYMERS, AND COPOLYMERS AND COATINGS CONTAINING THE SAME | OMNOVA SOLUTIONS INC (US) | 2006-08-09 | — | — | EP | disclosed |
| US-7087710-B2 | Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups | OMNOVA SOLUTIONS INC. (US) | 2006-08-08 | — | — | US | disclosed |
| US-20060162771-A1 | Sealing agent for photoelectric conversion element and photoelectric conversion device element using the same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2006-07-27 | — | — | US | disclosed |
| US-20060157173-A1 | Synthesis of energetic thermoplastic elastomers containing both polyoxirane and polyoxetane blocks | ALLIANT TECHSYSTEMS INC. | 2006-07-20 | — | — | US | disclosed |
| US-20060154083-A1 | Functional polymers via surface modifying agents, and methods for polymeric surface modification | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2006-07-13 | — | — | US | disclosed |
| US-20060135729-A1 | Amorphous polyether glycols based on bis-substituted oxetane monomers | AEROJET-GENERAL CORPORATION (US) | 2006-06-22 | — | — | US | disclosed |
| EP-1270563-B1 | FLUORINATED OXETANE DERIVATIVES AND PRODUCTION PROCESS THEREOF | DAIKIN IND LTD (JP) | 2006-06-07 | — | — | EP | disclosed |
| US-20060088716-A1 | Method for polymeric surface modification | WYNNE KENNETH J | 2006-04-27 | — | — | US | disclosed |
| US-7034064-B2 | Method of attaching a die to a substrate using a hybrid oxetane compound | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2006-04-25 | — | — | US | disclosed |
| US-7030242-B2 | Selective inhibition of aggrecanase in osteoarthritis treatment | PFIZER INC (US) | 2006-04-18 | — | — | US | disclosed |
| US-20060074215-A1 | Synthesis of energetic thermoplastic elastomers containing oligomeric urethane linkages | ALLIANT TECHSYSTEMS INC. | 2006-04-06 | — | — | US | disclosed |
| US-7022801-B2 | Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups | OMNOVA SOLUTIONS INC. (US) | 2006-04-04 | — | — | US | disclosed |
| US-20060051690-A1 | Aromatic heterocyclic-based charge transport materials having two amino groups | S-PRINTING SOLUTION CO., LTD. (KR) | 2006-03-09 | — | — | US | disclosed |
| WO-2006021218-A1 | POLYETHER POLYMER MATRIX | VERSAMATRIX A/S (DK) | 2006-03-02 | — | — | WO | disclosed |
| US-6997997-B1 | Method for the synthesis of energetic thermoplastic elastomers in non-halogenated solvents | ALLIANT TECHSYSTEMS INC. (US) | 2006-02-14 | — | — | US | disclosed |
| US-6998460-B2 | Amorphous polyether glycols based on bis-substituted oxetane and tetrahydrofuran monomers | AEROJET-GENERAL CORPORATION (US) | 2006-02-14 | — | — | US | disclosed |
| EP-1620418-A1 | OXETANE COMPOUNDS CONTAINING CINNAMYL FUNCTIONALITY | National Starch and Chemical Investment Holding Corporation (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1620417-A1 | OXETANE COMPOUNDS CONTAINING STYRENIC FUNCTIONALITY | National Starch and Chemical Investment Holding Corporation (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1620430-A1 | OXETANE COMPOUNDS CONTAINING MALEIMIDE FUNCTIONALITY | National Starch and Chemical Investment Holding Corporation (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1620488-A1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | National Starch and Chemical Investment Holding Corporation (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20060014918-A1 | COMPOSITIONS FOR USE IN GOLF BALLS | ACUSHNET COMPANY (US) | 2006-01-19 | — | — | US | disclosed |
| US-6982338-B2 | Oxetane compounds containing maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2006-01-03 | — | — | US | disclosed |
| US-6972317-B2 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. (US) | 2005-12-06 | — | — | US | disclosed |
| US-20050265685-A1 | Optical material containing photocurable fluoropolymer and photocurable fluororesin composition | DAIKIN INDUSTRIES, LTD (JP) | 2005-12-01 | — | — | US | disclosed |
| EP-1598897-A1 | SEALING AGENT FOR PHOTOELECTRIC CONVERSION ELEMENT AND PHOTOELECTRIC CONVERSION ELEMENT USING THE SAME | Nippon Kayaku Kabushiki Kaisha (JP) | 2005-11-23 | — | — | EP | disclosed |
| US-6962966-B2 | Monohydric polyfluorooxetane oligomers, polymers, and copolymers and coatings containing the same | OMNOVA SOLUTIONS INC. (US) | 2005-11-08 | — | — | US | disclosed |
| US-20050227997-A1 | 1-[4-(2-methyl-benzyloxy)-benzenesulfonyl]-4-aminoacetyl-3-methyl-piperazine-2-carboxylic acid hydroxyamide; potent enzyme inhibitor of metalloproteinases, for treating joint disease, prevent cartilage destruction | NOE MARK C | 2005-10-13 | — | — | US | disclosed |
| US-6953862-B2 | Oxetane compounds containing styrenic functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2005-10-11 | — | — | US | disclosed |
| US-20050209357-A1 | Flame retardant radiation curable compositions | DSM IP ASSETS B.V. (NL) | 2005-09-22 | — | — | US | disclosed |
| US-20050209437-A1 | Polymer compounds containing oxetane and maleimide functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2005-09-22 | — | — | US | disclosed |
| US-6943258-B2 | Polymer compounds containing oxetane and cinnamyl functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2005-09-13 | — | — | US | disclosed |
| US-20050192446-A1 | Polymer compounds containing oxetane and styrenic functionality | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2005-09-01 | — | — | US | disclosed |
| US-6927276-B2 | Monohydric polyfluorooxetane oligomers, polymers, and copolymers and coating containing the same | OMNOVA SOLUTIONS INC. (US) | 2005-08-09 | — | — | US | disclosed |
| US-20050154217-A1 | Amorphous polyether glycols based on bis-substituted oxetane and tetrahydrofuran monomers | AEROJET-GENERAL CORPORATION | 2005-07-14 | — | — | US | disclosed |
| EP-1548062-A1 | OPTICAL MATERIAL CONTAINING PHOTOCURABLE FLUOROPOLYMER AND PHOTOCURABLE FLUORORESIN COMPOSITION | Daikin Industries, Ltd. (JP) | 2005-06-29 | — | — | EP | disclosed |
| WO-2005054330-A1 | FLAME RETARDANT RADIATION CURABLE COMPOSITIONS | DSM IP ASSETS B.V. (NL) | 2005-06-16 | — | — | WO | disclosed |
| WO-2005047358-A1 | AQUEOUS HYDROPHOBIC AND OLEOPHOBIC COATING COMPOSITIONS, METHODS AND USES | OMNOVA SOLUTIONS INC. (US) | 2005-05-26 | — | — | WO | disclosed |
| US-6891013-B1 | Fluorinated polyurethane elastomers prepared from polyether prepolymers formed from mono-substituted fluorinated oxetane monomers and tetrahydrofuran | AEROJET-GENERAL CORPORATION (US) | 2005-05-10 | — | — | US | disclosed |
| US-20050084683-A1 | Method for polymeric surface modification | VIRGINIA COMMONWEALTH UNIVERSITY | 2005-04-21 | — | — | US | disclosed |
| WO-2005028550-A2 | METHOD FOR POLYMERIC SURFACE MODIFICATION | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2005-03-31 | — | — | WO | disclosed |
| US-6855775-B2 | Polymeric blocks of an oxetane oligomer, polymer or copolymer, containing ether side chains terminated by fluorinated aliphatic groups, and hydrocarbon polymers or copolymers | OMNOVA SOLUTIONS INC. (US) | 2005-02-15 | — | — | US | disclosed |
| WO-2005010074-A1 | RADIATION POLYMERIZATION OF FLUOROOXETANES | OMNOVA SOLUTIONS INC. (US) | 2005-02-03 | — | — | WO | disclosed |
| US-20040242804-A1 | Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups | OMNOVA SOLUTIONS INC. | 2004-12-02 | — | — | US | disclosed |
| US-6825316-B2 | FOR MAKING A FLUORINATED POLYETHERURETHANE COPOLYMER ELASTOMER; TEFLON SIMILAR NONSTICK COATINGS, HYDROPHOBIC, LOW SURFACE ENERGIES, LOW GLASS TRANSITION TEMPERATURES, NONABRASIVE AND TEAR STRENGTH, ADHESION | AEROJET-GENERAL CORPORATION | 2004-11-30 | — | — | US | disclosed |
| WO-2004101542-A1 | OXETANE COMPOUNDS CONTAINING CINNAMYL FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101550-A1 | OXETANE COMPOUNDS CONTAINING MALEIMIDE FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101541-A1 | OXETANE COMPOUNDS CONTAINING STYRENIC FUNCTIONALITY | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004101646-A1 | ADHESIVE COMPOSITIONS CONTAINING HYBRID OXETANE COMPOUNDS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION (US) | 2004-11-25 | — | — | WO | disclosed |
| US-20040225070-A1 | Oxetane compounds containing maleimide functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040225074-A1 | Adhesive compositions containing hybrid oxetane compounds | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040224164-A1 | Fluorinated polymer and amine resin compositions and products formed therefrom | OMNOVA SOLUTIONS INC. | 2004-11-11 | — | — | US | disclosed |
| US-20040225081-A1 | Oxetane compounds containing cinnamyl functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-20040225071-A1 | Oxetane compounds containing styrenic functionality | HENKEL AG & CO. KGAA (DE) | 2004-11-11 | — | — | US | disclosed |
| US-6815522-B1 | BINDER IN SOLID STATE AT ROOM TEMPERATURE HAVING A BLOCKS AND B BLOCKS CONNECTED VIA LINKING GROUPS DERIVED FROM URETHANE OLIGOMER DIOL; A BLOCKS ARE CRYSTALLINE BELOW ABOUT 60 DEGREES C.; B BLOCKS ARE AMORPHOUS ABOVE ABOUT -20 DEGREES C. | ALLIANT TECHSYSTEMS INC. | 2004-11-09 | — | — | US | disclosed |
| EP-1451228-A1 | FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM | Honeywell International, Inc. (US) | 2004-09-01 | — | — | EP | disclosed |
| EP-1448644-A2 | MATRIX FOR SOLID-PHASE ORGANIC SYNTHESIS | Carlsberg A/S (DK) | 2004-08-25 | — | — | EP | disclosed |
| US-6777563-B2 | FLUOROALKOXY-OXETANES | DAIKIN INDUSTRIES, LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| US-6753434-B1 | CURABLE; CATIONIC AND ANIONIC RING OPENING OR FREE RADICAL POLYMERIZABLE | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2004-06-22 | — | — | US | disclosed |
| EP-1425321-A2 | BEADED POLYETHYLENE GLYCOL-BASED RESINS | Carlsberg A/S (DK) | 2004-06-09 | — | — | EP | disclosed |
| JP-2004155767-A | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMER | AEROJET-GENERAL CORP | 2004-06-03 | — | — | JP | disclosed |
| US-20040097744-A1 | Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes | DAIKIN INDUSTRIES, LTD. (JP) | 2004-05-20 | — | — | US | disclosed |
| US-20040087759-A1 | Fluorinated thermoset polyurethane elastomers prepared from polyether prepolymers formed mono-substituted fluorinated oxetane monomers | AEROJET ROCKETDYNE, INC. (F/K/A AEROJET-GENERAL CORPORATION) | 2004-05-06 | — | — | US | disclosed |
| US-20040087759-A1 | Fluorinated thermoset polyurethane elastomers prepared from polyether prepolymers formed mono-substituted fluorinated oxetane monomers | AEROJET ROCKETDYNE, INC. (F/K/A AEROJET-GENERAL CORPORATION) | 2004-05-06 | — | — | US | disclosed |
| US-6727344-B2 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2004-04-27 | — | — | US | disclosed |
| US-20040048957-A1 | Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups | OMNOVA SOLUTIONS INC. | 2004-03-11 | — | — | US | disclosed |
| EP-1389224-A2 | POLYMERIC SURFACTANTS DERIVED FROM CYCLIC MONOMERS HAVING PENDANT FLUORINATED CARBON GROUPS | Omnova Soltions Inc (US) | 2004-02-18 | — | — | EP | disclosed |
| US-6686051-B1 | CLEANABLE STAIN AND WEAR RESISTANCE DRY ERASE LAMINIATES; AMINO RESIN CURED BLOCK PERFLUORO- SUBSTITUTED POLYETHER REACTED WITH DIBASIC ACID | OMNOVA SOLUTIONS INC. | 2004-02-03 | — | — | US | disclosed |
| US-6673948-B2 | FLUORINATION CORRESPONDING OXETANE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2004-01-06 | — | — | US | disclosed |
| US-6673947-B2 | ADDING A 3-ALKYLOXETANE METHANOL TO A FLUOROOLEFIN UNDER AN ALKALI CONDITION IN A SOLVENT AND AN ALKALI AQUEOUS SOLUTION IN PRESENCE OF (TETRABUTYLAMMONIUM CHLORIDE) A PHASE TRANSFER CATALYST | DAIKIN INDUSTRIES, INC. (JP) | 2004-01-06 | — | — | US | disclosed |
| US-6660828-B2 | Powder coating; fluorinated polyoxetanes; addition-condensation copolymer | OMNOVA SOLUTIONS INC. | 2003-12-09 | — | — | US | disclosed |
| US-20030208015-A1 | Monohydric polyfluorooxetane oligomers, polymers, and copolymers and coatings containing the same | OMNOVA SOLUTIONS INC. | 2003-11-06 | — | — | US | disclosed |
| US-6642334-B2 | Formed in silicone oil in presence of pentaalkyldisiloxane containing polymeric surfactant prepared by the copolymerization of an alkoxypolyoxyalkylenyl acrylate and an acrylic containing pentaalkyldisiloxane group | CARLSBERG A/S (DK) | 2003-11-04 | — | — | US | disclosed |
| EP-1144473-B1 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING BOTH POLYOXIRANE AND POLYOXETANE BLOCKS | ALLIANT TECHSYSTEMS INC (US) | 2003-09-24 | — | — | EP | disclosed |
| US-20030166785-A1 | Polymeric blocks of an oxetane oligomer, polymer or copolymer, containing ether side chains terminated by fluorinated aliphatic groups, and hydrocarbon polymers or copolymers | OMNOVA SOLUTIONS INC. | 2003-09-04 | — | — | US | disclosed |
| US-20030158373-A1 | Amorphous polyether glycols based on bis-substituted oxetane monomers | AEROJET-GENERAL CORPORATION (US) | 2003-08-21 | — | — | US | disclosed |
| US-20030149186-A1 | Monohydric polyfluorooxetane oligomers, polymers, and copolymers and coating containing the same | OMNOVA SOLUTIONS INC | 2003-08-07 | — | — | US | disclosed |
| US-20030144467-A1 | Matrix solid-phase organic synthesis | CARLSBERG A/S (DK) | 2003-07-31 | — | — | US | disclosed |
| US-20030138650-A1 | Polyester coetherified melamine formaldehyde copolymers | OMNOVA SOLUTIONS INC. | 2003-07-24 | — | — | US | disclosed |
| WO-2003051959-A1 | OXETANE BLOCK-CONTAINING COPOLYMERS | OMNOVA SOLUTIONS INC. (US) | 2003-06-26 | — | — | WO | disclosed |
| US-6579966-B1 | Copolymers of perfluoroalkyl containing polyethers with polycarboxylic acids and cured with amino resins; laminates with improved cleanable stain resistance | OMNOVA SOLUTIONS INC. | 2003-06-17 | — | — | US | disclosed |
| US-20030109662-A1 | Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups | DEUTSCHE BANK TRUST COMPANY AMERICAS | 2003-06-12 | — | — | US | disclosed |
| US-20030092862-A1 | Fluorinated short carbon atom side chain and polar group containing polymer, and flow, or leveling, or wetting agents thereof | OMNOVA SOLUTIONS INC. | 2003-05-15 | — | — | US | disclosed |
| WO-2003031489-A2 | MATRIX FOR SOLID-PHASE ORGANIC SYNTHESIS | CARLSBERG A/S (DK) | 2003-04-17 | — | — | WO | disclosed |
| US-20030065199-A1 | Fluorinated oxetane derivatives and production process thereof | DAIKIN INDUSTRIES, LTD. (JP) | 2003-04-03 | — | — | US | disclosed |
| EP-1297047-A2 | ANIONIC WATERBORNE POLYURETHANE DISPERSIONS CONTAINING POLYFLUOROOXETANES | OMNOVA SOLUTIONS INC. (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2003025039-A2 | BEADED POLYETHYLENE GLYCOL-BASED RESINS | CARLSBERG A/S (DK) | 2003-03-27 | — | — | WO | disclosed |
| US-20030060571-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2003-03-27 | — | — | US | disclosed |
| US-20030050415-A1 | Beaded polyethylene glycol-based resins | CARLSBERG A/S (DK) | 2003-03-13 | — | — | US | disclosed |
| US-20030045733-A1 | Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes | DAIKIN INDUSTRIES, LTD. (JP) | 2003-03-06 | — | — | US | disclosed |
| US-20030039919-A1 | Fluorine-containing compounds and polymers derived therefrom | HONEYWELL INTERNATIONAL INC. | 2003-02-27 | — | — | US | disclosed |
| EP-1141062-B1 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING OLIGOMERIC URETHANE LINKAGES | ALLIANT TECHSYSTEMS INC (US) | 2003-02-12 | — | — | EP | disclosed |
| EP-1270564-A1 | PROCESS FOR PREPARING 3-FLUOROALKOXYMETHYL-3-ALKYLOXETANES | Daikin Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1270563-A1 | FLUORINATED OXETANE DERIVATIVES AND PRODUCTION PROCESS THEREOF | Daikin Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| WO-2002102858-A1 | FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM | HONEYWELL INTERNATIONAL, INC. (US) | 2002-12-27 | — | — | WO | disclosed |
| WO-2002092660-A2 | POLYMERIC SURFACTANTS DERIVED FROM CYCLIC MONOMERS HAVING PENDANT FLUORINATED CARBON GROUPS | OMNOVA SOLTIONS INC (US) | 2002-11-21 | — | — | WO | disclosed |
| US-6479623-B1 | Amorphous polyether glycols based on bis-substituted oxetane monomers | OMNOVA SOLUTIONS, INC, | 2002-11-12 | — | — | US | disclosed |
| US-20020156200-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2002-10-24 | — | — | US | disclosed |
| US-6465566-B2 | REPEAT UNIT DERIVED FROM A HYDROXYL CONTAINING CARBOXYLIC ACID DISPERSANT | OMNOVA SOLUTIONS INC. | 2002-10-15 | — | — | US | disclosed |
| US-6465565-B1 | COATINGS MADE FROM POLYURETHANES CONTAINING POLYFLUOROOXETANE UNITS; LOW TEMPERATURE FLEXIBILITY, CHEMICAL RESISTANCE, ABRASION RESISTANCE, LOW COEFFICIENT OF FRICTION | OMNOVA SOLUTIONS, INC. | 2002-10-15 | — | — | US | disclosed |
| US-20020143112-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2002-10-03 | — | — | US | disclosed |
| EP-1244727-A1 | MONOHYDRIC POLYFLUOROOXETANE OLIGOMERS, POLYMERS, AND COPOLYMERS AND COATINGS CONTAINING THE SAME | OMNOVA SOLUTIONS INC. (US) | 2002-10-02 | — | — | EP | disclosed |
| US-20020137853-A1 | Monohydric polyfluorooxetane polymer and radiation curable coatings containing a monofunctional polyfluorooxetane polymer | OMNOVA SOLUTIONS INC. | 2002-09-26 | — | — | US | disclosed |
| US-20020127420-A1 | Two stage thermoformable fluorinated polyoxetane-polyester copolymers | DEUTSCHE BANK TRUST COMPANY AMERICAS | 2002-09-12 | — | — | US | disclosed |
| US-6448368-B1 | HYDROXY TERMINATED POLYETHERS HAVING ASYMMETRIC PENDANT ALKOXYMETHYLENE GROUPS; HYDROPHOBIC; PREPARATION OF POLYURETHANE ELASTOMERS, THERMOSET PLASTICS AND COATINGS | AEROJET-GENERAL CORPORATION | 2002-09-10 | — | — | US | disclosed |
| EP-1228121-A1 | AMORPHOUS POLYETHER GLYCOLS BASED ON BIS-SUBSTITUTED OXETANE MONOMERS | Aerojet-General Corporation (US) | 2002-08-07 | — | — | EP | disclosed |
| US-6417314-B1 | WEAR RESISTANCE, TEAR AND BONDING STRENGTH; COATINGS, PLASTICS | AEROJET-GENERAL CORPORATION | 2002-07-09 | — | — | US | disclosed |
| US-6403760-B1 | MONOHYDRIC TERMINATED POLYFLUOROOXETANE OLIGOMER OR POLYMER PRODUCED BY REACTING MONOALCOHOL WITH FLUOROOXETANE MONOMER HAVING SPECIFIED FORMULA | OMNOVA SOLUTIONS INC. | 2002-06-11 | — | — | US | disclosed |
| WO-2002034848-A1 | CURED POLYESTERS CONTAINING FLUORINATED SIDE CHAINS | OMNOVA SOLUTIONS INC. (US) | 2002-05-02 | — | — | WO | disclosed |
| US-6380351-B1 | FLUORINATED POLYETHERS | AEROJET-GENERAL CORPORATION | 2002-04-30 | — | — | US | disclosed |
| US-6359147-B1 | REACTING A HETERORING COMPOUND WITH CARBOXYLIC ACID OR DERIVATIVE | DIMENSION TECHNOLOGY CHEMICAL SYSTEMS, INC. | 2002-03-19 | — | — | US | disclosed |
| US-20020026006-A1 | Anionic waterborne polyurethane dispersions containing polyfluorooxetanes | DEUTSCHE BANK TRUST COMPANY AMERICAS, AS COLLATERAL AGENT | 2002-02-28 | — | — | US | disclosed |
| WO-2002004538-A2 | ANIONIC WATERBORNE POLYURETHANE DISPERSIONS CONTAINING POLYFLUOROOXETANES | OMNOVA SOLUTIONS INC. (US) | 2002-01-17 | — | — | WO | disclosed |
| EP-1144473-A2 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING BOTH POLYOXIRANE AND POLYOXETANE BLOCKS | Cordant Technologies, Inc. (US) | 2001-10-17 | — | — | EP | disclosed |
| EP-1141062-A2 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING OLIGOMERIC URETHANE LINKAGES | Cordant Technologies, Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000034209-A9 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING BOTH POLYOXIRANE AND POLYOXETANE BLOCKS | CORDANT TECH INC (US) | 2001-08-16 | — | — | WO | disclosed |
| WO-2001048051-A1 | MONOHYDRIC POLYFLUOROOXETANE OLIGOMERS, POLYMERS, AND COPOLYMERS AND COATINGS CONTAINING THE SAME | OMNOVA SOLUTIONS, INC. (US) | 2001-07-05 | — | — | WO | disclosed |
| EP-1081137-A1 | Selective inhibitors of aggrecanase in osteoarthritis treatment | Pfizer Products Inc. (US) | 2001-03-07 | — | — | EP | disclosed |
| WO-2001005871-A1 | AMORPHOUS POLYETHER GLYCOLS BASED ON BIS-SUBSTITUTED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 2001-01-25 | — | — | WO | disclosed |
| WO-2000034353-A9 | METHOD FOR THE SYNTHESIS OF THERMOPLASTIC ELASTOMERS IN NON-HALOGENATED SOLVENTS | CORDANT TECH INC (US) | 2000-11-30 | — | — | WO | disclosed |
| WO-2000034209-A2 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING BOTH POLYOXIRANE AND POLYOXETANE BLOCKS | CORDANT TECHNOLOGIES, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-2000034353-A2 | METHOD FOR THE SYNTHESIS OF THERMOPLASTIC ELASTOMERS IN NON-HALOGENATED SOLVENTS | CORDANT TECHNOLOGIES, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-2000034350-A2 | SYNTHESIS OF ENERGETIC THERMOPLASTIC ELASTOMERS CONTAINING OLIGOMERIC URETHANE LINKAGES | CORDANT TECHNOLOGIES, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| US-6037483-A | CHARGING REACTION VESSEL WITH AQUEOUS MIXTURE OF MONO-SUBSTITURED OXETANE, FLUOROALCOHOL, PHASE TRANSFER CATALYST AND STRONG BASE TO FORM REACTION MIXTURE; HEATING UNTIL REACTION IS COMPLETE | AEROJET-GENERAL CORPORATION (US) | 2000-03-14 | — | — | US | disclosed |
| WO-1998056500-A1 | USE OF CHROMIUM (III) CARBOXYLATES AS A CATALYST | DIMENSION TECHNOLOGY CHEMICAL SYSTEMS, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| EP-0811004-A4 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET GENERAL CO (US) | 1998-09-30 | — | — | EP | disclosed |
| EP-0811004-A4 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET GENERAL CO (US) | 1998-09-30 | — | — | EP | disclosed |
| US-5807977-A | Polyoxetanes based on pendant perfluoroalkyl side chains such as 3-methyl-3-(2,2,2-trifluoroethoxymethyl)-oxetane to form polyethers; very low surface energy, high hydrophobicity, low glass transition temperature and low coefficient of friction | AEROJET GENERAL CORPORATION (US) | 1998-09-15 | — | — | US | disclosed |
| US-5807977-A | Polyoxetanes based on pendant perfluoroalkyl side chains such as 3-methyl-3-(2,2,2-trifluoroethoxymethyl)-oxetane to form polyethers; very low surface energy, high hydrophobicity, low glass transition temperature and low coefficient of friction | AEROJET GENERAL CORPORATION (US) | 1998-09-15 | — | — | US | disclosed |
| US-5703194-A | WATERPROOFING; TEAR STRENGTH; BONDING STRENGTH | AEROJET-GENERAL CORPORATION (US) | 1997-12-30 | — | — | US | disclosed |
| US-5703194-A | WATERPROOFING; TEAR STRENGTH; BONDING STRENGTH | AEROJET-GENERAL CORPORATION (US) | 1997-12-30 | — | — | US | disclosed |
| EP-0811004-A1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 1997-12-10 | — | — | EP | disclosed |
| EP-0811004-A1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 1997-12-10 | — | — | EP | disclosed |
| US-5668250-A | Polyether coprepolymers formed from mono-substituted fluorinated oxetane monomers and tetrahydrofuran | AEROJET-GENERAL CORPORATION (US) | 1997-09-16 | — | — | US | disclosed |
| US-5668250-A | Polyether coprepolymers formed from mono-substituted fluorinated oxetane monomers and tetrahydrofuran | AEROJET-GENERAL CORPORATION (US) | 1997-09-16 | — | — | US | disclosed |
| US-5668251-A | Preparation of co-prepolymers from mono-substituted fluorinated monomers and tetrahydrofuran | AEROJET-GENERAL CORPORATION (US) | 1997-09-16 | — | — | US | disclosed |
| US-5668251-A | Preparation of co-prepolymers from mono-substituted fluorinated monomers and tetrahydrofuran | AEROJET-GENERAL CORPORATION (US) | 1997-09-16 | — | — | US | disclosed |
| US-5654450-A | THERMOPLASTIC RESIN INTERMEDIATES; TEAR STRENGTH, ADHESION | AEROJET-GENERAL CORPORATION (US) | 1997-08-05 | — | — | US | disclosed |
| US-5654450-A | THERMOPLASTIC RESIN INTERMEDIATES; TEAR STRENGTH, ADHESION | AEROJET-GENERAL CORPORATION (US) | 1997-08-05 | — | — | US | disclosed |
| US-5650483-A | PREPARING A SOLUTION OF A CATALYST, AN INITIATOR AND A SOLVENT, CONTACTING SOLUTION WITH A SECOND SOLUTION CONTAINING FLUORINATED OXETANE MONOMER(S) AND CONTROLLING THE TEMPERATURE OF THE MIXTURE | AEROJET-GENERAL CORPORATION (US) | 1997-07-22 | — | — | US | disclosed |
| US-5650483-A | PREPARING A SOLUTION OF A CATALYST, AN INITIATOR AND A SOLVENT, CONTACTING SOLUTION WITH A SECOND SOLUTION CONTAINING FLUORINATED OXETANE MONOMER(S) AND CONTROLLING THE TEMPERATURE OF THE MIXTURE | AEROJET-GENERAL CORPORATION (US) | 1997-07-22 | — | — | US | disclosed |
| WO-1997003105-A1 | PREPARATION OF CYCLIC OLIGOMERS OF SUBSTITUTED CYCLIC ETHERS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 1997-01-30 | — | — | WO | disclosed |
| WO-1996021657-A1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 1996-07-18 | — | — | WO | disclosed |
| WO-1996021657-A1 | MONO-SUBSTITUTED FLUORINATED OXETANE MONOMERS | AEROJET-GENERAL CORPORATION (US) | 1996-07-18 | — | — | WO | disclosed |
| EP-0000722-B1 | PROCESS FOR THE PREPARATION OF POLYURETHANES CONTAINING ARYLSULFONIC ACID ALKYL ESTER GROUPS | BAYER AG (DE) | 1982-09-29 | — | — | EP | disclosed |
| US-4237250-A | Polyurethanes containing aryl sulfonic acid alkyl ester groups | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-02 | — | — | US | disclosed |
| US-4211850-A | Polyhydroxy compounds containing urethane aryl sulfonic acid hydroxyalkyl ester groups | BAYER AKTIENGESELLSCHAFT (DE) | 1980-07-08 | — | — | US | disclosed |
| US-4201852-A | Polyurethanes based on modified polyisocyanates containing sulphonic acid ester groups and process for the production thereof | BAYER AKTIENGESELLSCHAFT (DE) | 1980-05-06 | — | — | US | disclosed |
| US-4189562-A | Polyhydroxy compounds containing urethane aryl sulfonic acid hydroxyalkyl ester groups | BAYER AKTIENGESELLSCHAFT (DE) | 1980-02-19 | — | — | US | disclosed |
| EP-0000723-A1 | Polyhydroxy compounds containing urethane-aryl-sulfonic acid-hydroxyalkyl ester groups, process for their preparation and their use as reaction components for the preparation of polyurethane resins | BAYER AG (DE) | 1979-02-21 | — | — | EP | disclosed |
| EP-0000723-A1 | Polyhydroxy compounds containing urethane-aryl-sulfonic acid-hydroxyalkyl ester groups, process for their preparation and their use as reaction components for the preparation of polyurethane resins | BAYER AG (DE) | 1979-02-21 | — | — | EP | disclosed |